Annotation,Domain ID,Annotation Members in Network,Annotation Members in Network Count,Summed Significance Score,Enrichment P-value,Enrichment Q-value,Depletion P-value,Depletion Q-value
'de novo' AMP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
'de novo' NAD biosynthetic process from tryptophan,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
'de novo' cotranslational protein folding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
'de novo' post-translational protein folding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
'de novo' protein folding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
'de novo' pyrimidine nucleobase biosynthetic process,101.0,CPA2;URA4;URA6,3.0,87.0,0.001,0.3021666666666667,1.0,1.0
(1->3)-beta-D-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
(1->6)-beta-D-glucan biosynthetic process,66.0,KRE6,1.0,67.12860956283974,0.019,0.9568611111111112,1.0,1.0
2-micrometer plasmid partitioning,101.0,KIP1,1.0,46.97387399036342,0.024,1.0,1.0,1.0
2-oxoglutarate metabolic process,106.0,KGD1;KGD2;LPD1,3.0,81.0,0.001,0.06714814814814815,1.0,1.0
5S class rRNA transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
7-methylguanosine RNA capping,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
7-methylguanosine mRNA capping,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ADP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ADP metabolic process,104.0,ADK1;ADK2;CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,19.0,124.14232024281705,0.001,0.06714814814814815,1.0,1.0
AMP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
AMP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ATP export,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ATP transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Arp2/3 complex-mediated actin nucleation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
CAAX-box protein maturation,39.0,STE24,1.0,70.46678962117541,0.021,0.6241475409836066,1.0,1.0
CDP-diacylglycerol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
COPII-coated vesicle budding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
COPII-coated vesicle cargo loading,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
CTP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
CUT metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Cvt vesicle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
D-ribose metabolic process,46.0,RBK1,1.0,54.84100481556973,0.011,1.0,1.0,1.0
DNA amplification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA double-strand break attachment to nuclear envelope,35.0,RTT107;SMC6,2.0,20.746623124624797,0.013,1.0,1.0,1.0
DNA double-strand break processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA duplex unwinding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA geometric change,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA protection,85.0,TSA1,1.0,20.0,0.01,0.8240909090909091,1.0,1.0
DNA replication checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA replication termination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"DNA replication, synthesis of RNA primer",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA replication-dependent chromatin assembly,34.0,ASF1;RTT106,2.0,17.239215679885945,0.007,1.0,1.0,1.0
DNA strand elongation,115.0,DPB4;MCM10;MCM2;MCM3;MCM4;MCM6;MCM7;POL1;POL2;PSF1;RFC1;RFC2;RFC3;RFC4;RFC5;TOP2,16.0,90.0,0.001,0.18130000000000002,1.0,1.0
DNA strand elongation involved in DNA replication,115.0,DPB4;MCM10;MCM2;MCM3;MCM4;MCM6;MCM7;POL1;POL2;PSF1;RFC1;RFC2;RFC3;RFC4;RFC5;TOP2,16.0,90.0,0.001,0.18130000000000002,1.0,1.0
DNA strand invasion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA synthesis involved in DNA repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA topological change,116.0,HMO1;RFA1;RFA2;RFA3;TOP2,5.0,27.885944983349926,0.047,1.0,0.999,1.0
DNA transport,66.0,POR1,1.0,67.12860956283974,0.019,0.9568611111111112,1.0,1.0
DNA unwinding involved in DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA-templated DNA replication maintenance of fidelity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA-templated transcription open complex formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
DNA-templated transcription termination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ER to Golgi ceramide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ER-associated misfolded protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ER-dependent peroxisome organization,75.0,DSL1;RTN1;RTN2;SEC39;YOP1,5.0,19.571160121408525,0.04,1.0,0.999,1.0
ESCRT III complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
G protein-coupled receptor signaling pathway,49.0,ASC1;IRA1,2.0,40.73323426647465,0.031,1.0,1.0,1.0
G1/S transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
G2/M transition of mitotic cell cycle,34.0,CDC28;CDC34;CDC53;CDC55;ORC1;POL2;SKP1;ZDS1,8.0,11.097729146242116,0.041,1.0,1.0,1.0
GMP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
GMP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
GPI anchor biosynthetic process,39.0,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6.0,126.0,0.001,0.045325000000000004,1.0,1.0
GPI anchor metabolic process,39.0,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6.0,126.0,0.001,0.045325000000000004,1.0,1.0
GTP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
GTP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi distribution to daughter cells,35.0,RET2,1.0,24.440336245779918,0.006,1.0,1.0,1.0
Golgi inheritance,35.0,RET2;SEC8,2.0,19.75468019078483,0.016,1.0,1.0,1.0
Golgi organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi to endosome transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi to plasma membrane protein transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi to plasma membrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi to vacuole transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi transport vesicle coating,35.0,GLO3,1.0,26.377340095392412,0.004,0.9065,1.0,1.0
Golgi vesicle budding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Golgi vesicle docking,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
IMP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
IMP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
IRE1-mediated unfolded protein response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-alpha-amino acid transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-methionine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-methionine salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-methionine salvage from S-adenosylmethionine,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-methionine salvage from methylthioadenosine,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-proline biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
L-serine biosynthetic process,106.0,LPD1;SER2,2.0,41.51525405672819,0.029,0.8762833333333334,1.0,1.0
L-serine catabolic process,116.0,CHA1;ILV1;SHM1;SHM2,4.0,30.57457106864421,0.035,1.0,1.0,1.0
L-serine metabolic process,106.0,CHA1;CYS4;ILV1;LPD1;MCY1;SER2;SHM1;SHM2,8.0,58.18235291961506,0.007,0.31727500000000003,1.0,1.0
MAPK cascade,33.0,AHK1;HOG1;HOS2;PBS2;SIF2;SNT1,6.0,57.0,0.001,0.10072222222222223,1.0,1.0
N-glycan processing,37.0,KTR3;MNN1,2.0,117.0,0.001,0.13946153846153847,1.0,1.0
N-terminal peptidyl-methionine acetylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
N-terminal protein amino acid acetylation,49.0,ARD1;MDM20;NAT1;NAT5,4.0,81.0,0.001,0.226625,1.0,1.0
N-terminal protein amino acid modification,49.0,ARD1;MDM20;NAT1;NAT5,4.0,81.0,0.001,0.226625,1.0,1.0
NAD biosynthesis via nicotinamide riboside salvage pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NAD biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NAD catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NAD metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NAD-cap decapping,95.0,RAI1;XRN1,2.0,43.6222983369181,0.021,1.0,1.0,1.0
NADH metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NADH oxidation,101.0,ADH3;GPD1;NDI1,3.0,39.62941478819199,0.043,1.0,0.998,1.0
NADH regeneration,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NADP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NADP metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NADPH regeneration,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
NLS-bearing protein import into nucleus,29.0,KAP114;KAP123;KAP95;NAP1;NSP1;NUP145;NUP53;NUP57;NUP60;SRP1,10.0,23.387640052032225,0.001,0.15108333333333335,1.0,1.0
P-body assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA (guanine-N7)-methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA decapping,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA folding,95.0,MSS116,1.0,50.923790185886176,0.011,1.0,1.0,1.0
RNA import into nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA polymerase I preinitiation complex assembly,81.0,RPA49;SPT15,2.0,59.6932101816387,0.035,1.0,0.999,1.0
RNA polymerase II core complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA polymerase II preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA polymerase III assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
RNA polymerase III preinitiation complex assembly,81.0,BDP1;BRF1;SPT15,3.0,110.65777017777677,0.002,0.4028888888888889,1.0,1.0
"RNA splicing, via endonucleolytic cleavage and ligation",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"RNA splicing, via transesterification reactions with guanosine as nucleophile",95.0,MSS116;NAM2,2.0,42.59507626354259,0.023,1.0,1.0,1.0
RNA surveillance,54.0,AIR2;CSL4;DIS3;DOM34;GBP2;LRP1;MLP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6;SUS1,20.0,62.064192560936135,0.001,0.06714814814814815,0.999,1.0
Ras protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
Rho protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
S-adenosylhomocysteine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
S-adenosylmethionine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
S-adenosylmethionine cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
S-adenosylmethionine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
SAGA complex localization to transcription regulatory region,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
SNARE complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
SNARE complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
SRP-dependent cotranslational protein targeting to membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"SRP-dependent cotranslational protein targeting to membrane, translocation",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
TOR signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
TORC1 signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
U1 snRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
U4 snRNA 3'-end processing,54.0,LRP1;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,11.0,69.01029995663981,0.001,0.06714814814814815,1.0,1.0
U5 snRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
UTP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
UV-damage excision repair,112.0,RSC2,1.0,42.258012586952255,0.012,1.0,1.0,1.0
[2Fe-2S] cluster assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
acetate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
acetate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
acetate transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
acetyl-CoA biosynthetic process,106.0,LAT1;LPD1;PDA1;PDB1;PDX1,5.0,81.0,0.001,0.06714814814814815,1.0,1.0
acetyl-CoA metabolic process,106.0,KGD2;LAT1;LPD1;PDA1;PDB1;PDX1,6.0,81.0,0.001,0.06714814814814815,1.0,1.0
actin cortical patch assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin cortical patch localization,28.0,BSP1;LAS17;LSB3;MYO3;MYO5;VRP1;YSC84,7.0,19.131441621885788,0.043,1.0,1.0,1.0
actin cortical patch organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin filament bundle organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin filament depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin filament polymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin filament severing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin filament-based transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin nucleation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actin polymerization or depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actomyosin contractile ring contraction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
actomyosin contractile ring organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
acylglycerol catabolic process,35.0,AYR1;CDC28;TGL4;YJU3,4.0,20.06299615038751,0.015,1.0,1.0,1.0
acylglycerol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adaptation of signaling pathway by response to pheromone involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adenine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adenine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adenine nucleotide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adenylate cyclase-modulating G protein-coupled receptor signaling pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
adhesion between unicellular organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aerobic electron transport chain,66.0,COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1,18.0,117.0,0.001,0.09542105263157895,1.0,1.0
agglutination involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aggregation of unicellular organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
alcohol catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aldehyde biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
alditol catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
alditol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
alditol phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aldonic acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
allantoin metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
alpha-amino acid catabolic process,106.0,ALT1;BNA4;CAR1;CHA1;EHD3;GLY1;ILV1;KGD2;LPD1;PDC1;PUT2;SAH1;SHM1;SHM2,14.0,81.0,0.001,0.06714814814814815,1.0,1.0
amide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino acid activation,46.0,ARC1;CDC60;CRS1;DED81;DPS1;GLN4;GRS1;GUS1;HTS1;ILS1;KRS1;MES1;MSK1;NAM2;SES1;SLM5;THS1;TYS1;VAS1;YDR341C;YHR020W,21.0,84.0,0.001,0.259,1.0,1.0
amino acid catabolic process to alcohol via Ehrlich pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino acid catabolic process via Ehrlich pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino acid import across plasma membrane,75.0,GNP1;MUP3,2.0,25.95420750050467,0.014,1.0,1.0,1.0
amino acid transmembrane export from vacuole,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino sugar biosynthetic process,75.0,BCH1;BMH1;BMH2;CHS3,4.0,22.42883987859147,0.025,1.0,1.0,1.0
amino sugar metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
amino-acid betaine metabolic process,106.0,AIM17;CAT2,2.0,37.74438023414501,0.04,0.9418181818181819,1.0,1.0
aminoacyl-tRNA metabolism involved in translational fidelity,46.0,CDC60;ILS1;NAM2;VAS1;YHR020W,5.0,75.57116012140852,0.002,0.3296363636363636,1.0,1.0
aminoglycan metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aminophospholipid transport,75.0,DNF1;DNF2;DRS2;LEM3;MMM1,5.0,42.0,0.001,0.259,1.0,1.0
anaerobic respiration,66.0,PET9,1.0,64.64551544793402,0.022,0.99715,1.0,1.0
anaphase-promoting complex-dependent catabolic process,27.0,APC1;APC11;APC2;APC4;APC5;CDC16;CDC23;CDC26;CDC27;DOC1;MND2,11.0,36.0,0.001,0.1295,1.0,1.0
antisense RNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
antisense RNA transcript catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
apoptotic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
arginine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
arginine catabolic process,101.0,CAR1,1.0,55.70374386461888,0.012,1.0,1.0,1.0
arginine metabolic process,101.0,CAR1;CPA2,2.0,45.49045083938936,0.027,1.0,1.0,1.0
aromatic amino acid family biosynthetic process,101.0,ARO3;TRP5,2.0,44.59045806093028,0.029,1.0,1.0,1.0
aromatic amino acid family catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aromatic amino acid family catabolic process to alcohol via Ehrlich pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aromatic amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ascospore wall biogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ascospore-type prospore assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ascospore-type prospore membrane formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
aspartate family amino acid catabolic process,106.0,CHA1;GLY1;ILV1;KGD2,4.0,68.11772612256911,0.003,0.16996875,1.0,1.0
assembly of actomyosin apparatus involved in cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
assembly of actomyosin apparatus involved in mitotic cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
assembly of large subunit precursor of preribosome,121.0,DBP10;NIP7;NOG1;NOP2;RLP24;RPF2;SPB4;TIF6,8.0,144.0,0.001,0.45325,1.0,1.0
astral microtubule organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
asymmetric protein localization to old or new spindle pole body,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
attachment of meiotic spindle microtubules to kinetochore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
attachment of mitotic spindle microtubules to kinetochore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
attachment of spindle microtubules to kinetochore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
autophagosome maturation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
autophagosome-lysosome fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
autophagy of mitochondrion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
autophagy of peroxisome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
axial cellular bud site selection,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
base-excision repair,112.0,APN1;POL2;STH1,3.0,59.37734009539241,0.002,0.518,1.0,1.0
"base-excision repair, gap-filling",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
basic amino acid transmembrane export from vacuole,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
basic amino acid transmembrane import into vacuole,26.0,VSB1;YPQ2,2.0,50.37052604415186,0.033,1.0,1.0,1.0
basic amino acid transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
benzene-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
beta-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
biogenic amine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
biogenic amine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
biological process involved in interspecies interaction between organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
biological process involved in intraspecies interaction between organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
bipolar cellular bud site selection,28.0,MYO3;MYO5;PAN1;VRP1,4.0,22.677042616037514,0.024,1.0,0.999,1.0
box C/D RNA 3'-end processing,42.0,NOP1;PXR1,2.0,15.137272471682024,0.003,1.0,1.0,1.0
box C/D RNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
box C/D snoRNP assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
box H/ACA RNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
box H/ACA snoRNP assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
branched-chain amino acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
branched-chain amino acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
branched-chain amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
budding cell apical bud growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
budding cell bud growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcineurin-mediated signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcium ion homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcium ion transmembrane import into cytosol,26.0,YVC1,1.0,57.76498014742464,0.02,1.0,1.0,1.0
calcium ion transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcium ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
calcium-mediated signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbohydrate derivative transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbohydrate transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbon catabolite activation of transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbon catabolite activation of transcription from RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbon catabolite regulation of transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbon catabolite regulation of transcription from RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
carbon catabolite repression of transcription,77.0,SPT6;TUP1;VPS36,3.0,11.123231785930573,0.014,1.0,1.0,1.0
carbon catabolite repression of transcription from RNA polymerase II promoter by glucose,77.0,SPT6;TUP1;VPS36,3.0,11.123231785930573,0.014,1.0,1.0,1.0
catabolite repression,77.0,SPT6;TUP1;VPS36,3.0,11.123231785930573,0.014,1.0,1.0,1.0
cell adhesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell adhesion involved in single-species biofilm formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell cycle DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell morphogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell morphogenesis involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell redox homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell wall (1->3)-beta-D-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell wall assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell wall beta-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell wall chitin biosynthetic process,75.0,BCH1;BMH1;BMH2;CHS3,4.0,22.42883987859147,0.025,1.0,1.0,1.0
cell wall chitin metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell wall mannoprotein biosynthetic process,37.0,ANP1;HOC1;KTR1;KTR3;MNN10;MNN9;PSA1;VAN1,8.0,117.0,0.001,0.13946153846153847,1.0,1.0
cell wall polysaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell-cell adhesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cell-substrate adhesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular aldehyde metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular bud neck septin ring organization,25.0,CDC11;SHS1,2.0,21.0,0.001,0.1295,1.0,1.0
cellular bud site selection,25.0,BUD31;BUD32;BUD4;CDC24;CHS5;ERV14;MYO3;MYO5;NBA1;PAN1;VRP1,11.0,11.214419939295736,0.025,1.0,1.0,1.0
cellular detoxification of aldehyde,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular hyperosmotic response,26.0,GPD1;PBS2;VPH1,3.0,44.83779792923003,0.048,1.0,0.998,1.0
cellular lipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular metabolic compound salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular modified amino acid biosynthetic process,88.0,AIM17;FOL2;MIS1;MTD1,4.0,21.73978756120893,0.028,1.0,0.999,1.0
cellular modified amino acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular modified amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular oxidant detoxification,23.0,AHP1;CCP1;CCS1;GRX2;GRX7;MRP1;RSM26;SOD1;SOD2;TRR1;TSA1;URE2,12.0,8.023453009910556,0.046,1.0,0.999,1.0
cellular response to UV,112.0,RSC2,1.0,42.258012586952255,0.012,1.0,1.0,1.0
cellular response to acid chemical,22.0,KOG1;NTH1;TPS1;YNL190W,4.0,18.45558775792689,0.021,1.0,0.999,1.0
cellular response to amino acid starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to amino acid stimulus,22.0,KOG1,1.0,23.703921559843174,0.007,1.0,1.0,1.0
cellular response to anoxia,66.0,FSF1,1.0,67.12860956283974,0.019,0.9568611111111112,1.0,1.0
cellular response to arsenic-containing substance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to carbohydrate stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to decreased oxygen levels,66.0,FSF1,1.0,67.12860956283974,0.019,0.9568611111111112,1.0,1.0
cellular response to desiccation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to endogenous stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to environmental stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to glucose starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to heat,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to inorganic substance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to light stimulus,112.0,RSC2,1.0,42.258012586952255,0.012,1.0,1.0,1.0
cellular response to methylmercury,22.0,BOP3,1.0,23.06601014308862,0.008,1.0,1.0,1.0
cellular response to misfolded protein,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to monosaccharide stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to nitrogen compound,22.0,DAL82;KOG1;YPK1,3.0,20.06299615038751,0.015,1.0,1.0,1.0
cellular response to nitrogen starvation,21.0,CCL1;KIN28,2.0,18.0,0.001,0.259,1.0,1.0
cellular response to organonitrogen compound,22.0,DAL82;KOG1,2.0,20.392591607539384,0.014,1.0,1.0,1.0
cellular response to osmotic stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to oxygen radical,23.0,CCS1;MRP1;RSM26;SOD1;SOD2;TRR1,6.0,9.612359947967773,0.025,1.0,1.0,1.0
cellular response to oxygen-containing compound,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to phosphate starvation,26.0,PHM8;SYG1,2.0,51.77787733953148,0.03,1.0,1.0,1.0
cellular response to radiation,112.0,RSC2,1.0,42.258012586952255,0.012,1.0,1.0,1.0
cellular response to reactive oxygen species,23.0,CCS1;MRP1;RSM26;SOD1;SOD2;TRR1,6.0,9.612359947967773,0.025,1.0,1.0,1.0
cellular response to salt,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to toxic substance,23.0,AHP1;CCP1;CCS1;GRX2;GRX7;MRP1;OSI1;RSM26;SOD1;SOD2;TRR1;TSA1;URE2,13.0,7.8061799739838875,0.05,1.0,0.999,1.0
cellular response to unfolded protein,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to water deprivation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to water stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cellular response to xenobiotic stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
centromere complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
centromere localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ceramide biosynthetic process,39.0,LAC1;LAG1;LCB1;LCB2;LIP1,5.0,126.0,0.001,0.045325000000000004,1.0,1.0
ceramide metabolic process,39.0,LAC1;LAG1;LCB1;LCB2;LIP1,5.0,126.0,0.001,0.045325000000000004,1.0,1.0
ceramide transport,75.0,DNF1;DNF2;NVJ2;OSH3,4.0,42.0,0.001,0.259,1.0,1.0
chaperone cofactor-dependent protein refolding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chaperone-mediated protein complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chaperone-mediated protein folding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chemotropism,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chloride transport,73.0,IST2,1.0,22.21848749616356,0.006,1.0,1.0,1.0
chorismate metabolic process,101.0,ARO3,1.0,52.08052050297818,0.016,1.0,1.0,1.0
chromatin remodeling at centromere,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chromosome attachment to the nuclear envelope,35.0,RTT107;SMC6,2.0,20.746623124624797,0.013,1.0,1.0,1.0
chromosome condensation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chromosome localization to nuclear envelope involved in homologous chromosome segregation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
chromosome organization involved in meiotic cell cycle,91.0,CDC28;RDH54;SCP160;YCG1,4.0,22.723462454131038,0.038,1.0,1.0,1.0
chromosome separation,27.0,APC11;APC5;CDC16;CDC23;CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;SMC5;SMC6;TPD3;YCG1,15.0,36.0,0.001,0.1295,1.0,1.0
citrulline biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
clathrin coat assembly,28.0,SLA2,1.0,32.21441993929574,0.005,0.32375,1.0,1.0
clathrin coat disassembly,85.0,SSA1,1.0,21.54901959985743,0.007,0.7050555555555557,1.0,1.0
clathrin-coated vesicle cargo loading,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"clathrin-coated vesicle cargo loading, AP-1-mediated",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
clathrin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cobalt ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
coenzyme A biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
coenzyme A metabolic process,39.0,CAB3;HMG1;HMG2;SIS2,4.0,113.35674018211279,0.002,0.08633333333333335,1.0,1.0
copper ion export,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
copper ion homeostasis,113.0,CCC2;HAA1;HHT1;HHT2;SOD1;TMN2,6.0,54.0,0.001,0.18130000000000002,1.0,1.0
copper ion import,73.0,FRE1;FRE4,2.0,21.54901959985743,0.007,1.0,1.0,1.0
copper ion transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
copper ion transport,73.0,CCC2;FRE1;FRE4;QDR2,4.0,18.23908740944319,0.015,1.0,1.0,1.0
cotranslational protein targeting to membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cristae formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cyclic threonylcarbamoyladenosine biosynthetic process,66.0,TCD1;TCD2,2.0,117.0,0.001,0.09542105263157895,1.0,1.0
cysteine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cysteine biosynthetic process from serine,66.0,CYS4;MCY1,2.0,54.94848032596658,0.039,1.0,0.999,1.0
cysteine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytochrome complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytogamy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoplasm protein quality control,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoplasm protein quality control by the ubiquitin-proteasome system,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoplasmic microtubule organization,46.0,NUD1;SPC98,2.0,43.47957512241786,0.028,1.0,1.0,1.0
cytoplasmic translational elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoplasmic translational initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytoskeleton-dependent intracellular transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
cytosolic ribosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
dTMP biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
deadenylation-dependent decapping of nuclear-transcribed mRNA,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
deadenylation-independent decapping of nuclear-transcribed mRNA,19.0,CDC36;DCP2;EDC1;MOT2;NOT5;RAI1,6.0,16.468364969380165,0.01,1.0,0.991,1.0
deoxyribonucleoside monophosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
deoxyribonucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
dephosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
detection of chemical stimulus,85.0,SIS1,1.0,23.979400086720375,0.004,0.45325,1.0,1.0
detoxification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
dicarboxylic acid biosynthetic process,106.0,AAT2;ARO3;BNA4;FOL2;GDH1;IDH1;IDH2;IDP1;MIS1;PUT2,10.0,81.0,0.001,0.06714814814814815,1.0,1.0
dicarboxylic acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
dicarboxylic acid metabolic process,106.0,AAT2;ARO3;BNA4;FOL2;FUM1;GDH1;HOM3;IDH1;IDH2;IDP1;KGD1;KGD2;LPD1;MDH1;MDH2;MIS1;PCS60;PUT2;SHM1;SHM2,20.0,81.0,0.001,0.06714814814814815,1.0,1.0
dicarboxylic acid transport,85.0,BPT1;OAC1;TNA1;YCF1;YHM2,5.0,13.872161432802645,0.041,1.0,0.999,1.0
diol biosynthetic process,39.0,FOL2;LCB1;LCB2;LCB5;MCO14;TIM54,6.0,96.64325981788721,0.005,0.185,1.0,1.0
diphosphoinositol polyphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
disaccharide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
disaccharide metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
division septum assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
dolichol-linked oligosaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
donor selection,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
double-strand break repair via break-induced replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
double-strand break repair via nonhomologous end joining,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
double-strand break repair via synthesis-dependent strand annealing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
early endosome to Golgi transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
eisosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endocytic recycling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",51.0,BMS1;DBP8;DIP2;EMG1;ESF2;FCF1;FCF2;LCP5;LOC1;MPP10;MRD1;NOC4;NOP14;NOP58;PWP2;RCL1;ROK1;RRP5;RRP9;SAS10;TOM1;UTP10;UTP11;UTP13;UTP14;UTP18;UTP20;UTP23;UTP6;UTP7,30.0,83.8034049270106,0.004,1.0,1.0,1.0
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"endonucleolytic cleavage in ITS1 upstream of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",122.0,BRX1;DBP7;RRP5,3.0,37.6472696601843,0.027,1.0,1.0,1.0
"endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum inheritance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum membrane fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum membrane organization,73.0,CDC48;IST2;SCS2;UFE1,4.0,16.77780705266081,0.021,1.0,1.0,1.0
endoplasmic reticulum organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum polarization,25.0,SCS2;SHS1,2.0,17.660151216962362,0.003,0.3399375,1.0,1.0
endoplasmic reticulum tubular network maintenance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum tubular network organization,75.0,PER33;RTN1;RTN2;YOP1,4.0,21.120936286320184,0.031,1.0,1.0,1.0
endoplasmic reticulum unfolded protein response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endoplasmic reticulum-plasma membrane tethering,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endosomal vesicle fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endosome organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
endosome to plasma membrane protein transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"energy coupled proton transmembrane transport, against electrochemical gradient",66.0,COX1,1.0,63.17176157324736,0.024,1.0,1.0,1.0
energy reserve metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
enzyme-directed rRNA pseudouridine synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
error-prone translesion synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of chromosome localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of mitochondrion localization,28.0,AIM21;ARC18;ARP2;MDM10,4.0,42.0,0.001,0.09542105263157895,1.0,1.0
establishment of mitotic sister chromatid cohesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of mitotic spindle localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of mitotic spindle orientation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to chromosome,18.0,GAL11;SIN4,2.0,38.3020835598307,0.015,1.0,1.0,1.0
establishment of protein localization to endoplasmic reticulum,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to endoplasmic reticulum membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to extracellular region,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to mitochondrial membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to peroxisome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein localization to plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of protein-containing complex localization to telomere,81.0,SIR2;SIR3,2.0,54.069109267600915,0.048,1.0,1.0,1.0
establishment of sister chromatid cohesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment of spindle localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment or maintenance of actin cytoskeleton polarity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
establishment or maintenance of cytoskeleton polarity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ethanol catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ethanol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ether metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
exit from mitosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
exocyst assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
exocyst localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
exocytic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
exonucleolytic catabolism of deadenylated mRNA,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",54.0,CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,14.0,67.4827324828878,0.001,0.06714814814814815,1.0,1.0
"exonucleolytic trimming to generate mature 5'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",121.0,BRX1;RLP7,2.0,85.04721520490303,0.022,1.0,1.0,1.0
export across plasma membrane,73.0,PDR15;PDR5;PMA1;PMA2;QDR2;SAP185;SNQ2,7.0,14.089353929735006,0.039,1.0,1.0,1.0
facultative heterochromatin formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid alpha-oxidation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid beta-oxidation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid beta-oxidation using acyl-CoA dehydrogenase,106.0,AIM45;CIR1,2.0,41.92673315376008,0.028,0.8752413793103448,1.0,1.0
fatty acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid derivative metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid oxidation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fatty acid transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fermentation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
folic acid biosynthetic process,88.0,FOL2;MIS1,2.0,24.773715100704173,0.017,1.0,1.0,1.0
folic acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
folic acid-containing compound biosynthetic process,88.0,FOL2;MIS1;MTD1,3.0,22.42883987859147,0.025,1.0,0.999,1.0
folic acid-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
formation of cytoplasmic translation initiation complex,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
formation of translation preinitiation complex,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
formin-nucleated actin cable organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"fructose 1,6-bisphosphate metabolic process",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fructose 6-phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fructose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fructose transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fumarate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fungal-type cell wall (1->3)-beta-D-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fungal-type cell wall assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fungal-type cell wall beta-glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
fungal-type cell wall chitin biosynthetic process,75.0,BCH1;BMH1;BMH2;CHS3,4.0,22.42883987859147,0.025,1.0,1.0,1.0
fungal-type cell wall polysaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
gamma-tubulin complex localization to mitotic spindle pole body,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
gene conversion,18.0,POL2;SOH1,2.0,34.80912370273367,0.022,1.0,1.0,1.0
generation of catalytic spliceosome for first transesterification step,10.0,IST3;PRP19;PRP2;SNU114;SPP381;SYF1;YJU2,7.0,147.08577268848296,0.001,0.259,1.0,1.0
generation of catalytic spliceosome for second transesterification step,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
global genome nucleotide-excision repair,113.0,HHT1;HHT2;PAF1;RTF1,4.0,54.0,0.001,0.18130000000000002,1.0,1.0
glucan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glucan catabolic process,73.0,CDC28;EXG2;GDB1;GPH1,4.0,16.989700043360187,0.02,1.0,0.999,1.0
glucosamine-containing compound biosynthetic process,75.0,BCH1;BMH1;BMH2;CHS3,4.0,22.42883987859147,0.025,1.0,1.0,1.0
glucosamine-containing compound catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glucosamine-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glucose 6-phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glucose mediated signaling pathway,49.0,ASC1;GPB2;YCK1,3.0,38.34584289134614,0.038,1.0,1.0,1.0
glucose transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glutamate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glutamate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glutamine family amino acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glutamine family amino acid catabolic process,101.0,CAR1;PUT2,2.0,45.965772908846304,0.026,1.0,1.0,1.0
glutamine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glutathione catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glutathione metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glyceraldehyde-3-phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycerol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycerol catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycerol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycerol transmembrane transport,101.0,RGC1,1.0,54.695642783101775,0.013,1.0,1.0,1.0
glycerol-3-phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycerolipid catabolic process,35.0,AYR1;CDC28;GDE1;NTE1;PGC1;PLB1;TGL4;YJU3,8.0,15.144257805623093,0.042,1.0,1.0,1.0
glycerophospholipid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycine biosynthetic process,116.0,GLY1;SHM1;SHM2,3.0,32.28964204412191,0.029,1.0,1.0,1.0
glycine metabolic process,116.0,GLY1;LPD1;SHM1;SHM2,4.0,29.587643252443513,0.039,1.0,1.0,1.0
glycogen biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycogen catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycogen metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycolipid biosynthetic process,39.0,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6.0,126.0,0.001,0.045325000000000004,1.0,1.0
glycolytic fermentation to ethanol,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycoprotein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycosyl compound biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycosyl compound catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glycosyl compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glyoxylate cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
glyoxylate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
heme transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
heteroduplex formation,91.0,RDH54;RFA1;RFA2;RFA3,4.0,21.5485997795945,0.045,1.0,0.999,1.0
hexose biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
hexose catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
histidine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
histone catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
histone mRNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
histone modification,9.0,ADA2;SUS1,2.0,81.0,0.001,0.6043333333333334,1.0,1.0
homocysteine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
homologous chromosome pairing at meiosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
homologous chromosome segregation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
homoserine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
homoserine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
hydrogen peroxide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
hydrogen peroxide metabolic process,85.0,AHP1;CCP1;LPD1;TSA1,4.0,16.382721639824073,0.023,1.0,1.0,1.0
hydrogen sulfide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
hyperosmotic response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
import across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inclusion body assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
indole-containing compound biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
indole-containing compound catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
indole-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inner mitochondrial membrane organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inorganic anion transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inorganic anion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inorganic cation import across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inositol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inositol phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
inositol phosphoceramide metabolic process,37.0,AUR1,1.0,66.25983016910473,0.02,1.0,1.0,1.0
integrated stress response signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intein-mediated protein splicing,26.0,VMA1,1.0,61.05992058969856,0.016,1.0,1.0,1.0
intermembrane lipid transfer,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
internal protein amino acid acetylation,9.0,ADA2,1.0,50.054543036687576,0.014,1.0,1.0,1.0
interstrand cross-link repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intra-Golgi vesicle-mediated transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular calcium ion homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular copper ion homeostasis,113.0,HAA1;HHT1;HHT2;SOD1;TMN2,5.0,54.0,0.001,0.18130000000000002,1.0,1.0
intracellular distribution of mitochondria,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular glucose homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular lipid transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular mRNA localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular magnesium ion homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular manganese ion homeostasis,37.0,GDT1;PMR1;SMF3;SPF1,4.0,117.0,0.001,0.13946153846153847,1.0,1.0
intracellular nitrogen homeostasis,8.0,ADY2;ATO2;DAL82;URE2;VID30,5.0,10.193820026016112,0.02,1.0,1.0,1.0
intracellular pH reduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular protein transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular sphingolipid homeostasis,75.0,GNP1,1.0,29.356740182112787,0.008,1.0,1.0,1.0
intracellular sterol transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intracellular zinc ion homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intralumenal vesicle formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
intron homing,26.0,VMA1,1.0,61.05992058969856,0.016,1.0,1.0,1.0
iron coordination entity transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
iron import into cell,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
iron ion transmembrane transport,46.0,ENB1;SIT1,2.0,43.47957512241786,0.028,1.0,1.0,1.0
iron ion transport,73.0,AIM14;ENB1;FRE1;FRE4;PET9;SIT1;SMF3;TDH3,8.0,14.559319556497243,0.035,1.0,0.998,1.0
isoleucine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
isoleucine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
isoprenoid biosynthetic process,39.0,HMG1;HMG2,2.0,126.0,0.001,0.045325000000000004,1.0,1.0
isoprenoid metabolic process,39.0,ALG9;DPM1;HMG1;HMG2;OST1,5.0,126.0,0.001,0.045325000000000004,1.0,1.0
karyogamy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
karyogamy involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
kinetochore assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
kinetochore organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
kynurenine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lactate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lactate catabolic process,66.0,DLD1,1.0,69.0124920662473,0.017,0.9568611111111112,1.0,1.0
lactate metabolic process,66.0,DLD1;DLD3,2.0,54.94848032596658,0.039,1.0,1.0,1.0
lagging strand elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
leading strand elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
leucine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
leucine catabolic process,106.0,LPD1,1.0,48.48876046829003,0.016,0.6906666666666668,1.0,1.0
leucine metabolic process,106.0,BAT1;BAT2;LEU4;LPD1,4.0,81.0,0.001,0.06714814814814815,1.0,1.0
lipid droplet formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipid droplet organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipid homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipid modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipid storage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipid translocation,75.0,DNF1;DNF2;DRS2;LEM3;YPK1,5.0,42.0,0.001,0.259,1.0,1.0
lipoate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lipoprotein biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
liposaccharide metabolic process,39.0,CDC1;CWH43;DPM1;GAA1;GPI16;MCD4,6.0,126.0,0.001,0.045325000000000004,1.0,1.0
long-chain fatty acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
long-chain fatty acid import into cell,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
long-chain fatty acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
long-chain fatty acid transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lysine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lysine biosynthetic process via aminoadipic acid,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
lysine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA 3'-splice site recognition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA 5'-splice site recognition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA branch site recognition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"mRNA cis splicing, via spliceosome",10.0,CBC2;CLF1;CWC15;PRP21;PRP39;PRP40;PRP42;PRP8;PRP9;SNU66;YHC1,11.0,161.38764005203222,0.001,0.259,1.0,1.0
mRNA export from nucleus in response to heat stress,29.0,NUP120;NUP133;NUP188;NUP60;NUP84,5.0,18.65473387604259,0.005,1.0,1.0,1.0
mRNA methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA polyadenylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA pseudouridine synthesis,23.0,CBF5;PUS4,2.0,13.806179973983888,0.005,1.0,1.0,1.0
mRNA splice site recognition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mRNA stabilization,93.0,ATP25,1.0,56.79961213041151,0.011,1.0,1.0,1.0
maintenance of DNA repeat elements,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of DNA trinucleotide repeats,79.0,CTF18;CTF8;DCC1;SEM1,4.0,18.0,0.001,0.226625,1.0,1.0
maintenance of RNA location,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of cell polarity,25.0,CDC12;OSH3;PXL1,3.0,13.445731277666626,0.012,1.0,1.0,1.0
maintenance of location in cell,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of mitotic sister chromatid cohesion,79.0,DCC1,1.0,15.137272471682024,0.003,0.5439,1.0,1.0
maintenance of protein localization in endoplasmic reticulum,37.0,EMP24;EPS1;ERD2;ERP1;ERP2;ERP4;RER1,7.0,117.0,0.001,0.13946153846153847,1.0,1.0
maintenance of protein localization in organelle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of protein location,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of protein location in cell,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of protein location in nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maintenance of rDNA,34.0,ORC1;PBP1,2.0,16.0,0.01,1.0,1.0,1.0
maintenance of sister chromatid cohesion,79.0,DCC1,1.0,15.137272471682024,0.003,0.5439,1.0,1.0
maintenance of transcriptional fidelity during transcription elongation,81.0,RPB9,1.0,72.55159422349077,0.017,1.0,1.0,1.0
maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II,81.0,RPB9,1.0,72.55159422349077,0.017,1.0,1.0,1.0
maintenance of translational fidelity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
malate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
manganese ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mannan biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mannose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mannose transmembrane transport,73.0,HXT1;HXT2;HXT5,3.0,17.21246399047171,0.019,1.0,1.0,1.0
mannosylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mating type determination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mating type switching,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
maturation of 5S rRNA,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiosis II cell cycle process,91.0,RDH54,1.0,32.0,0.01,1.0,1.0,1.0
meiotic DNA double-strand break formation,7.0,BRE1;MCM21;RTF1;SET1;SPP1;SWD3;YCG1,7.0,18.0,0.001,0.9065,1.0,1.0
meiotic DNA double-strand break processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic cell cycle checkpoint signaling,122.0,DSL1;FPR3,2.0,39.78185566026706,0.022,1.0,1.0,1.0
meiotic cell cycle phase transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic chromosome condensation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic chromosome separation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic gene conversion,18.0,SOH1,1.0,39.60718960155644,0.013,1.0,1.0,1.0
meiotic mismatch repair,101.0,MSH3,1.0,48.06974225615605,0.022,1.0,1.0,1.0
meiotic recombination checkpoint signaling,122.0,FPR3,1.0,46.099650094857004,0.012,1.0,1.0,1.0
meiotic sister chromatid segregation,91.0,RDH54,1.0,32.0,0.01,1.0,1.0,1.0
meiotic spindle assembly checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic spindle disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
meiotic spindle organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
membrane addition at site of cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
membrane assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
membrane biogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
metallo-sulfur cluster assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
metaphase/anaphase transition of mitotic cell cycle,27.0,APC1;APC11;APC2;APC5;CDC16;CDC23;CDC27;CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;SDS24;SWM1;TPD3,17.0,36.0,0.001,0.1295,1.0,1.0
methionine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
methionine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
methylguanosine-cap decapping,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microlipophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule depolymerization,101.0,KIP1;MHP1,2.0,39.62941478819199,0.043,1.0,1.0,1.0
microtubule nucleation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule organizing center localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule organizing center organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule polymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule polymerization or depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
microtubule-based movement,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
misfolded protein transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mismatch repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondria-associated ubiquitin-dependent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial ATP synthesis coupled electron transport,66.0,COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1,18.0,117.0,0.001,0.09542105263157895,1.0,1.0
mitochondrial ATP transmembrane transport,66.0,PET9,1.0,64.64551544793402,0.022,0.99715,1.0,1.0
mitochondrial DNA metabolic process,95.0,MHR1;PIM1;RIM1,3.0,34.28772782823473,0.048,1.0,0.999,1.0
mitochondrial DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial RNA 5'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial RNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial RNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial RNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial cytochrome c oxidase assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"mitochondrial electron transport, cytochrome c to oxygen",66.0,COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8,8.0,117.0,0.001,0.09542105263157895,1.0,1.0
"mitochondrial electron transport, succinate to ubiquinone",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"mitochondrial electron transport, ubiquinol to cytochrome c",66.0,CYT1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1,8.0,117.0,0.001,0.09542105263157895,1.0,1.0
mitochondrial fission,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial genome maintenance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial outer membrane translocase complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial phosphate ion transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial protein processing,66.0,AFG3;COR1;CYM1;YTA12,4.0,117.0,0.001,0.09542105263157895,1.0,1.0
mitochondrial proton-transporting ATP synthase complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial respirasome assembly,66.0,COX13,1.0,68.04437230097106,0.018,0.9568611111111112,1.0,1.0
mitochondrial respiratory chain complex III assembly,66.0,QCR7;QCR9,2.0,117.0,0.001,0.09542105263157895,1.0,1.0
mitochondrial respiratory chain complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial ribosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial tRNA 5'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial tRNA modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial tRNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial tRNA thio-modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial transcription,95.0,MSS116;RPO41,2.0,38.866100563682444,0.032,1.0,1.0,1.0
mitochondrial translational elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrial translational initiation,24.0,AIM23;IFM1;MRP21;MRP51;RSM28,5.0,88.77528010406445,0.001,1.0,1.0,1.0
mitochondrial transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrion distribution,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrion inheritance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrion localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitochondrion morphogenesis,66.0,PHB1,1.0,70.03932067641894,0.016,0.9568611111111112,1.0,1.0
mitochondrion-endoplasmic reticulum membrane tethering,46.0,MDM10;MMM1;NVJ2,3.0,38.84205201184738,0.041,1.0,1.0,1.0
mitophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic DNA damage checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic DNA integrity checkpoint signaling,34.0,BRE1;CDC28;FAR11;ORC1;POL2,5.0,13.260618553422349,0.022,1.0,1.0,1.0
mitotic DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic DNA replication checkpoint signaling,34.0,ORC1;POL2,2.0,16.77528010406445,0.008,1.0,1.0,1.0
mitotic DNA replication initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic DNA replication preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic G1/S transition checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic G2/M transition checkpoint,34.0,CDC55;ORC1;POL2,3.0,13.95781995917355,0.018,1.0,1.0,1.0
mitotic actomyosin contractile ring contraction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic actomyosin contractile ring disassembly,27.0,APC2,1.0,26.662184995396274,0.006,0.627576923076923,1.0,1.0
mitotic chromosome condensation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic cytokinetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic division septum assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic intra-S DNA damage checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic morphogenesis checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic sister chromatid biorientation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic sister chromatid cohesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle formation (spindle phase one),-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
mitotic spindle orientation checkpoint signaling,22.0,ARP1;BMH1;KIN4,3.0,19.46506186483899,0.017,1.0,1.0,1.0
monoatomic anion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
monocarboxylic acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
monocarboxylic acid transport,85.0,ADY2;ATO2;FAA4;OAC1;VHT1;YBT1,6.0,13.767507096020994,0.042,1.0,1.0,1.0
monosaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
monosaccharide catabolic process,46.0,PFK1;PFK2;RBK1,3.0,43.92181460354835,0.027,1.0,1.0,1.0
monosaccharide transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ncRNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ncRNA export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of ATP-dependent activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of Arp2/3 complex-mediated actin nucleation,28.0,LSB1;SLA1;SLA2,3.0,42.0,0.001,0.09542105263157895,1.0,1.0
negative regulation of DNA amplification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA replication origin binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA-templated DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of DNA-templated DNA replication initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"negative regulation of DNA-templated transcription, elongation",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of G1/S transition of mitotic cell cycle,6.0,ASH1;BRE1,2.0,22.503332396167426,0.009,0.49445454545454537,1.0,1.0
negative regulation of G2/M transition of mitotic cell cycle,34.0,CDC55;ORC1;POL2,3.0,13.95781995917355,0.018,1.0,1.0,1.0
negative regulation of Ras protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of Rho protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of TORC1 signaling,5.0,IML1;NPR2;NPR3;PBP1,4.0,18.0,0.001,0.10072222222222223,1.0,1.0
negative regulation of actin filament bundle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of actin filament depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of actin filament polymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of actin nucleation,28.0,HOF1;LSB1;SLA1;SLA2,4.0,42.0,0.001,0.09542105263157895,1.0,1.0
negative regulation of antisense RNA transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of apoptotic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of autophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of autophagy of mitochondrion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of carbohydrate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cell cycle G2/M phase transition,34.0,CDC55;ORC1;POL2,3.0,13.95781995917355,0.018,1.0,1.0,1.0
negative regulation of cell cycle checkpoint,27.0,MND2,1.0,24.5490898867281,0.009,0.627576923076923,1.0,1.0
negative regulation of cell division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cellular catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of chromosome organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of clathrin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cytoplasmic mRNA processing body assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cytoplasmic translation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of cytoskeleton organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of developmental process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of double-strand break repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of double-strand break repair via nonhomologous end joining,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of endoplasmic reticulum unfolded protein response,112.0,ISW1,1.0,45.00666479233485,0.009,1.0,1.0,1.0
negative regulation of establishment of protein localization,39.0,SCS2;SPC2;STE24,3.0,126.0,0.001,0.045325000000000004,1.0,1.0
negative regulation of exit from mitosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of filamentous growth,18.0,DIG1;DIG2;SSN3,3.0,36.63927739283057,0.018,1.0,1.0,1.0
negative regulation of formin-nucleated actin cable assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of gluconeogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of glucose mediated signaling pathway,49.0,ASC1,1.0,47.7778791227866,0.017,1.0,1.0,1.0
negative regulation of growth of unicellular organism as a thread of attached cells,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of heterochromatin organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of intracellular signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of intracellular transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of invasive growth in response to glucose limitation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of lipid biosynthetic process,22.0,GTS1;MOT3;SEI1;YPK1,4.0,18.02099380380648,0.023,1.0,0.999,1.0
negative regulation of lipid metabolic process,22.0,GTS1;MOT3;SEI1;YPK1,4.0,18.02099380380648,0.023,1.0,0.999,1.0
negative regulation of mRNA 3'-end processing,95.0,NAB2,1.0,47.42162726455229,0.015,1.0,1.0,1.0
negative regulation of mRNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mRNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mRNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of macroautophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of meiotic DNA double-strand break formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of meiotic cell cycle,33.0,CDC28;DSL1;FPR3;HOS2;PDR16;RPD3;SET2;SET3;SIF2,9.0,57.0,0.001,0.10072222222222223,1.0,1.0
negative regulation of meiotic cell cycle phase transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of meiotic nuclear division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of metaphase/anaphase transition of cell cycle,27.0,CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;TPD3,8.0,15.82510515149295,0.048,1.0,0.999,1.0
negative regulation of metaphase/anaphase transition of meiotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of microtubule depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of microtubule polymerization or depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mitochondrion organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mitophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mitotic cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mitotic recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of mitotic spindle assembly checkpoint signaling,27.0,MND2,1.0,24.5490898867281,0.009,0.627576923076923,1.0,1.0
negative regulation of molecular function,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of nuclear division,33.0,CDC55;CTF19;CTF3;DSL1;FPR3;GAC1;GLC7;HOS2;MND2;RPD3;SET2;SET3;SIF2;TPD3,14.0,51.280430082384356,0.002,0.1908421052631579,1.0,1.0
"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",95.0,NAB2,1.0,47.42162726455229,0.015,1.0,1.0,1.0
negative regulation of nucleocytoplasmic transport,112.0,ISW1;SCS2,2.0,40.78518321507877,0.014,1.0,1.0,1.0
negative regulation of organelle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion,37.0,AKR1,1.0,61.17681319779948,0.027,1.0,1.0,1.0
negative regulation of phosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phosphatidylinositol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phospholipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phospholipid translocation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phosphorus metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of phosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"negative regulation of post-translational protein targeting to membrane, translocation",39.0,SPC2;STE24,2.0,126.0,0.001,0.045325000000000004,1.0,1.0
negative regulation of programmed cell death,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of proteasomal protein catabolic process,27.0,MND2;UBP6,2.0,21.550560208128903,0.016,0.9669333333333334,1.0,1.0
negative regulation of proteasomal ubiquitin-dependent protein catabolic process,27.0,MND2,1.0,24.5490898867281,0.009,0.627576923076923,1.0,1.0
negative regulation of protein depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein import into nucleus during spindle assembly checkpoint,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein kinase C signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein localization,39.0,SCS2;SPC2;STE24,3.0,126.0,0.001,0.045325000000000004,1.0,1.0
negative regulation of protein localization to nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein modification by small protein conjugation or removal,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein modification process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein phosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein polymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein-containing complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of protein-containing complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of proteolysis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of proteolysis involved in protein catabolic process,27.0,MND2;UBP6,2.0,21.550560208128903,0.016,0.9669333333333334,1.0,1.0
negative regulation of pseudohyphal growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of rDNA heterochromatin formation,6.0,CTI6;DEP1;PHO23;RPD3;RXT2;SAP30;SDS3;SIN3,8.0,33.0,0.001,0.06475,1.0,1.0
negative regulation of reciprocal meiotic recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of reproductive process,33.0,AKR1;CDC28;DSL1;FPR3;HOS2;MCM21;PDR16;RPD3;SET2;SET3;SIF2;YCG1,12.0,57.0,0.001,0.10072222222222223,1.0,1.0
negative regulation of ribosomal protein gene transcription by RNA polymerase II,18.0,SRB2,1.0,41.130753611677285,0.011,1.0,1.0,1.0
negative regulation of septation initiation signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of sexual sporulation resulting in formation of a cellular spore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of silent mating-type cassette heterochromatin formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of sister chromatid cohesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of small GTPase mediated signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of small molecule metabolic process,22.0,FYV10;GID7;GID8;MOT3;RMD5;VID24;VID28;VID30,8.0,14.814662348471218,0.045,1.0,1.0,1.0
negative regulation of sphingolipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of sporulation resulting in formation of a cellular spore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of supramolecular fiber organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of telomere maintenance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of telomere maintenance via telomere lengthening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of termination of DNA-templated transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of transcription by RNA polymerase I,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of transcription by transcription factor localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of transcription regulatory region DNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of translation in response to stress,95.0,AAT2;SBP1,2.0,38.866100563682444,0.032,1.0,1.0,1.0
negative regulation of translational elongation,49.0,ASC1;DHH1,2.0,40.00012362329705,0.033,1.0,1.0,1.0
negative regulation of translational frameshifting,49.0,ASC1,1.0,47.7778791227866,0.017,1.0,1.0,1.0
negative regulation of translational initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of translational initiation in response to stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
negative regulation of transmembrane transport,39.0,SPC2;STE24,2.0,126.0,0.001,0.045325000000000004,1.0,1.0
negative regulation of transport,39.0,AKL1;ISW1;NPR1;SCS2;SEC6;SPC2;STE24;YPK1,8.0,76.6041671196614,0.015,0.485625,0.999,1.0
negative regulation of ubiquitin-dependent protein catabolic process,27.0,MND2,1.0,24.5490898867281,0.009,0.627576923076923,1.0,1.0
neutral amino acid transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
neutral lipid catabolic process,35.0,AYR1;CDC28;TGL4;YJU3,4.0,20.06299615038751,0.015,1.0,1.0,1.0
neutral lipid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nicotinamide nucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nicotinamide riboside metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nicotinate nucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nitrate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nitrogen catabolite activation of transcription from RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nitrogen catabolite regulation of transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nitrogen catabolite regulation of transcription from RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nitrogen cycle metabolic process,101.0,CAR1;URE2,2.0,42.5871114057746,0.034,1.0,1.0,1.0
nonfunctional rRNA decay,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear RNA surveillance,54.0,AIR2;CSL4;DIS3;GBP2;LRP1;MLP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6;SUS1,19.0,62.064192560936135,0.001,0.06714814814814815,0.999,1.0
nuclear cell cycle DNA replication initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear mRNA surveillance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear mRNA surveillance of mRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear migration by microtubule mediated pushing forces,33.0,TUB1;TUB3,2.0,28.934696160326414,0.03,1.0,1.0,1.0
nuclear migration involved in conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear polyadenylation-dependent CUT catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear polyadenylation-dependent antisense transcript catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear polyadenylation-dependent mRNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear polyadenylation-dependent ncRNA catabolic process,54.0,AIR2;CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,16.0,63.48945498979339,0.001,0.06714814814814815,1.0,1.0
nuclear polyadenylation-dependent rRNA catabolic process,54.0,AIR2;CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6,15.0,64.31308981988553,0.001,0.06714814814814815,1.0,1.0
nuclear polyadenylation-dependent snoRNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear polyadenylation-dependent tRNA catabolic process,54.0,AIR2;CSL4;DIS3;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,13.0,70.70202231334012,0.001,0.06714814814814815,1.0,1.0
nuclear pore complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear pore localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear pore organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear protein quality control by the ubiquitin-proteasome system,85.0,CDC48;SIS1,2.0,20.45757490560675,0.009,0.8240909090909091,1.0,1.0
"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, RNase MRP-dependent",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay",19.0,CDC36;DCP2;DCS1;EDC1;MOT2;NOT5;RAI1;XRN1,8.0,14.988068274463389,0.012,1.0,0.989,1.0
"nuclear-transcribed mRNA catabolic process, exonucleolytic",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, no-go decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, non-stop decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nuclear-transcribed mRNA poly(A) tail shortening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleic acid phosphodiester bond hydrolysis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleobase biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleobase metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleobase-containing small molecule catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleolar chromatin organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleolar large rRNA transcription by RNA polymerase I,81.0,BUD27;CDC73;CTR9;HPR1;LEO1;MOT1;PAF1;RPA12;RPA135;RPA14;RPA190;RPA34;RPA43;RPA49;RRN10;RRN9;RTF1;SPT15;SPT4;SPT5,20.0,123.0,0.001,0.259,1.0,1.0
nucleolus organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleoside diphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleoside diphosphate catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GDA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,18.0,102.3185983500683,0.001,0.06714814814814815,1.0,1.0
nucleoside diphosphate metabolic process,104.0,ADK1;ADK2;CDC19;ENO1;ENO2;FBA1;GDA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1;URA6,21.0,119.14481819962737,0.001,0.06714814814814815,1.0,1.0
nucleoside metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleoside monophosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleoside monophosphate phosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleoside phosphate catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GDA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;PHM8;TDH1;TDH2;TDH3;TPI1,19.0,100.9131940654002,0.001,0.06714814814814815,1.0,1.0
nucleoside triphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleosome disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleosome organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleotide catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;PHM8;TDH1;TDH2;TDH3;TPI1,18.0,101.75111837637937,0.001,0.06714814814814815,1.0,1.0
nucleotide salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleotide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"nucleotide-excision repair, DNA gap filling",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
nucleotide-sugar biosynthetic process,75.0,PSA1;SEC53,2.0,25.95420750050467,0.014,1.0,1.0,1.0
nucleotide-sugar metabolic process,75.0,PSA1;SEC53,2.0,25.95420750050467,0.014,1.0,1.0,1.0
nucleus localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
olefinic compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
oligopeptide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
oligosaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
oligosaccharide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
oligosaccharide-lipid intermediate biosynthetic process,39.0,ALG2;ALG9;DPM1;OST1,4.0,100.71348036422557,0.004,0.15108333333333335,1.0,1.0
one-carbon compound transport,5.0,NPR2,1.0,18.0,0.001,0.10072222222222223,1.0,1.0
one-carbon metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
organelle localization by membrane tethering,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
organelle transport along microtubule,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
organic cation transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
organic hydroxy compound catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
organic hydroxy compound transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ornithine metabolic process,101.0,CAR1,1.0,55.70374386461888,0.012,1.0,1.0,1.0
osmosensory signaling MAPK cascade,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
osmosensory signaling pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
osmosensory signaling pathway via Sho1 osmosensor,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
outer mitochondrial membrane organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
oxidative phosphorylation,66.0,ATP15;ATP2;ATP5;COX1;COX12;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1,22.0,117.0,0.001,0.09542105263157895,1.0,1.0
pentose catabolic process,46.0,RBK1,1.0,54.84100481556973,0.011,1.0,1.0,1.0
pentose metabolic process,46.0,RBK1,1.0,54.84100481556973,0.011,1.0,1.0,1.0
pentose-phosphate shunt,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"pentose-phosphate shunt, non-oxidative branch",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peptide catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peptide mating pheromone maturation involved in positive regulation of conjugation with cellular fusion,39.0,STE24,1.0,70.46678962117541,0.021,0.6241475409836066,1.0,1.0
peptide pheromone maturation,39.0,STE24,1.0,70.46678962117541,0.021,0.6241475409836066,1.0,1.0
peptidyl-histidine modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peptidyl-lysine methylation,46.0,RKM4,1.0,52.80958613540861,0.013,1.0,1.0,1.0
peptidyl-lysine modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peptidyl-lysine monomethylation,46.0,RKM4,1.0,52.80958613540861,0.013,1.0,1.0,1.0
peroxisomal membrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peroxisome fission,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
peroxisome inheritance,22.0,KIN4,1.0,23.703921559843174,0.007,1.0,1.0,1.0
phenol-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphate ion transmembrane transport,26.0,MIR1;PHO87;PHO90;PHO91;SYG1,5.0,85.77787733953147,0.003,0.3399375,1.0,1.0
phosphate ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidic acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylcholine acyl-chain remodeling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylcholine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylcholine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylglycerol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylinositol dephosphorylation,73.0,INP51;INP53;IST2;SCS2,4.0,17.21246399047171,0.019,1.0,1.0,1.0
phosphatidylinositol phosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylinositol-3-phosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylinositol-mediated signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phosphatidylserine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phospholipid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
phospholipid dephosphorylation,73.0,INP51;INP53;IST2;SCS2,4.0,17.21246399047171,0.019,1.0,1.0,1.0
phospholipid translocation,75.0,DNF1;DNF2;DRS2;LEM3;YPK1,5.0,42.0,0.001,0.259,1.0,1.0
phospholipid transport,75.0,DNF1;DNF2;DRS2;LEM3;MDM10;MMM1;NVJ2;PDR16;YPK1,9.0,42.0,0.001,0.259,1.0,1.0
phytosteroid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
piecemeal microautophagy of the nucleus,126.0,ATG13;CDC48;OSH3;TRS85;VAC8;VAM6;VPS33;VPS41,8.0,13.705908707523038,0.03,1.0,1.0,1.0
plasma membrane organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
plasma membrane selenite transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
plasma membrane tubulation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
plasmid maintenance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
plasmid partitioning,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
poly(A)+ mRNA export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
polyadenylation-dependent RNA catabolic process,54.0,AIR2;CSL4;DIS3;LRP1;MPP6;MTR3;MTR4;RAI1;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,16.0,63.48945498979339,0.001,0.06714814814814815,1.0,1.0
polyadenylation-dependent snoRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
polyol biosynthetic process,39.0,FOL2;GPP1;LCB1;LCB2;LCB5;MCO14;TIM54,7.0,88.07022054633836,0.008,0.27892307692307694,1.0,1.0
polyol catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
polyol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
polyol transmembrane transport,101.0,RGC1,1.0,54.695642783101775,0.013,1.0,1.0,1.0
polyphosphate biosynthetic process,26.0,VTC1;VTC4;VTC5,3.0,102.0,0.001,0.1295,1.0,1.0
polyphosphate metabolic process,26.0,PHO87;PHO90;PHO91;VPH1;VTC1;VTC2;VTC3;VTC4;VTC5,9.0,102.0,0.001,0.1295,1.0,1.0
polyprenol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
polysaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
polysaccharide catabolic process,73.0,CDC28;DSE4;EXG2;GDB1;GPH1,5.0,15.85026652029182,0.026,1.0,0.999,1.0
positive regulation of ATP-dependent activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of Arp2/3 complex-mediated actin nucleation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of Atg1/ULK1 kinase complex assembly,21.0,CCL1;KIN28,2.0,18.0,0.001,0.259,1.0,1.0
positive regulation of DNA binding,77.0,SPT6;SUA7,2.0,12.27454494336405,0.009,1.0,1.0,1.0
positive regulation of DNA metabolic process,21.0,BDF1;CDC28;HSP82;MHR1;RAD3;RFA1;RFM1;RIM1;SBA1;SUM1;SWI6;VTS1,12.0,9.718732549730364,0.024,1.0,0.999,1.0
positive regulation of DNA recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of DNA replication origin binding,77.0,SPT6,1.0,14.387640052032225,0.004,0.9065,1.0,1.0
positive regulation of DNA-templated DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of DNA-templated DNA replication initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of DNA-templated transcription initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of G1/S transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of G2/M transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of MAPK cascade,33.0,AHK1;HOS2;PBS2;SIF2;SNT1,5.0,57.0,0.001,0.10072222222222223,1.0,1.0
positive regulation of RNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of RNA polymerase II transcription preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of RNA splicing,13.0,NAM8,1.0,45.59771852360797,0.015,1.0,1.0,1.0
positive regulation of SNARE complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of TOR signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of TORC1 signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of actin filament bundle assembly,28.0,LAS17;PFY1,2.0,24.773715100704173,0.017,0.9942258064516131,1.0,1.0
positive regulation of actin filament depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of actin nucleation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of attachment of spindle microtubules to kinetochore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of autophagosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of autophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of binding,77.0,MPT5;SNU13;SPT6;SUA7;YHC1,5.0,9.718732549730364,0.024,1.0,1.0,1.0
positive regulation of carbohydrate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of catalytic activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell adhesion involved in single-species biofilm formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell communication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell cycle checkpoint,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell cycle phase transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cell growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cellular response to amino acid starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cellular response to drug,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cellular response to heat,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of chromosome organization,27.0,HSP82;MND2;RFA1;SBA1,4.0,17.62225299549294,0.034,1.0,0.999,1.0
positive regulation of chromosome segregation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of clathrin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"positive regulation of cytokinesis, actomyosin contractile ring assembly",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of cytoplasmic mRNA processing body assembly,22.0,CAF20,1.0,25.311329952303794,0.005,1.0,1.0,1.0
positive regulation of cytoskeleton organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of developmental process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of double-strand break repair,113.0,BDF1;CDC28,2.0,33.36969535779172,0.014,1.0,1.0,1.0
positive regulation of double-strand break repair via homologous recombination,113.0,BDF1;CDC28,2.0,33.36969535779172,0.014,1.0,1.0,1.0
positive regulation of endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of endodeoxyribonuclease activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of endoplasmic reticulum unfolded protein response,22.0,KIN2,1.0,25.311329952303794,0.005,1.0,1.0,1.0
positive regulation of establishment of protein localization,66.0,ALY2;POR1,2.0,56.304202470075786,0.036,1.0,1.0,1.0
positive regulation of exit from mitosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of filamentous growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of filamentous growth of a population of unicellular organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of filamentous growth of a population of unicellular organisms in response to starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of formation of translation preinitiation complex,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of formin-nucleated actin cable assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of gluconeogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of glucose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of glycerol transport,101.0,RGC1,1.0,54.695642783101775,0.013,1.0,1.0,1.0
positive regulation of growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of growth of unicellular organism as a thread of attached cells,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of hydrolase activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of intracellular protein transport,66.0,POR1,1.0,67.12860956283974,0.019,0.9568611111111112,1.0,1.0
positive regulation of intracellular signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of intracellular transport,65.0,POR1;RIO2,2.0,104.88786667138505,0.023,1.0,1.0,1.0
positive regulation of invasive growth in response to glucose limitation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of lipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of lipid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of lipid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mRNA processing,13.0,NAM8,1.0,45.59771852360797,0.015,1.0,1.0,1.0
"positive regulation of mRNA splicing, via spliceosome",13.0,NAM8,1.0,45.59771852360797,0.015,1.0,1.0,1.0
positive regulation of macroautophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mating type switching,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of meiotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of meiotic nuclear division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of metaphase/anaphase transition of cell cycle,27.0,APC11;APC5;CDC16;CDC23;MND2,5.0,36.0,0.001,0.1295,1.0,1.0
positive regulation of microtubule polymerization or depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitochondrial DNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitochondrial fission,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitochondrial fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitochondrion organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitotic actomyosin contractile ring disassembly,27.0,APC2,1.0,26.662184995396274,0.006,0.627576923076923,1.0,1.0
positive regulation of mitotic cell cycle,27.0,APC11;APC5;CCR4;CDC16;CDC23;CDC25;CDC28;CDC55;CYS4;GID8;GLC7;MND2;NUD1;SDA1;XRN1;ZDS1,16.0,36.0,0.001,0.1295,1.0,1.0
positive regulation of mitotic cell cycle phase transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitotic cytokinetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of mitotic spindle pole body separation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of molecular function,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of monoatomic ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of nuclear cell cycle DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of nuclear division,27.0,APC11;APC5;CDC16;CDC23;CPR1;MND2;SWI6,7.0,36.0,0.001,0.1295,1.0,1.0
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of nuclease activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of nucleocytoplasmic transport,65.0,POR1;RIO2,2.0,104.88786667138505,0.023,1.0,1.0,1.0
positive regulation of organelle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of phosphorus metabolic process,25.0,ASC1;CDC11;CDC12;RPP1B;VAC14,5.0,21.0,0.001,0.1295,1.0,1.0
positive regulation of phosphorylation,25.0,ASC1;CDC11;CDC12;RPP1B;VAC14,5.0,21.0,0.001,0.1295,1.0,1.0
positive regulation of programmed cell death,101.0,NDI1,1.0,53.7622869653311,0.014,1.0,1.0,1.0
positive regulation of protein autoubiquitination,27.0,MND2,1.0,24.5490898867281,0.009,0.627576923076923,1.0,1.0
positive regulation of protein catabolic process,64.0,RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,6.0,111.82510515149295,0.001,0.09542105263157895,0.999,1.0
positive regulation of protein import into nucleus,66.0,POR1,1.0,67.12860956283974,0.019,0.9568611111111112,1.0,1.0
positive regulation of protein localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein localization to nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein modification by small protein conjugation or removal,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein modification process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein phosphorylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein ubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein-containing complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of protein-containing complex disassembly,46.0,ANB1;HYP2;TWF1,3.0,75.57116012140852,0.002,0.3296363636363636,1.0,1.0
positive regulation of proteolysis,64.0,RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,6.0,111.82510515149295,0.001,0.09542105263157895,0.999,1.0
positive regulation of proteolysis involved in protein catabolic process,64.0,RPT1;RPT2;RPT3;RPT4;RPT5;RPT6,6.0,111.82510515149295,0.001,0.09542105263157895,0.999,1.0
positive regulation of pseudohyphal growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of rRNA processing,49.0,CCM1;NAN1;RIO1,3.0,38.04125561028453,0.039,1.0,1.0,1.0
positive regulation of receptor internalization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of receptor-mediated endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of reproductive process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of response to extracellular stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of ribosomal protein gene transcription by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of secretion by cell,22.0,KIN2,1.0,25.311329952303794,0.005,1.0,1.0,1.0
positive regulation of signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of small molecule metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of stress-activated protein kinase signaling cascade,33.0,HOS2;SIF2;SNT1,3.0,57.0,0.001,0.10072222222222223,1.0,1.0
positive regulation of supramolecular fiber organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of telomere maintenance via telomere lengthening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transcription by RNA polymerase I,81.0,BUD27;CDC73;CTR9;HPR1;LEO1;NAN1;PAF1;RTF1;SNF6;SPT4;SPT5;UTP10;UTP15;UTP4;UTP5;UTP8;UTP9,17.0,59.6932101816387,0.035,1.0,0.996,1.0
positive regulation of transcription by RNA polymerase III,95.0,NAB2,1.0,47.42162726455229,0.015,1.0,1.0,1.0
positive regulation of transcription by galactose,18.0,SRB8;SSN2;SSN3;SSN8,4.0,63.0,0.001,0.20144444444444445,1.0,1.0
positive regulation of transcription elongation by RNA polymerase I,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transcription elongation by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transcription from RNA polymerase II promoter by galactose,18.0,SSN2;SSN3,2.0,63.0,0.001,0.20144444444444445,1.0,1.0
positive regulation of transcription from RNA polymerase II promoter by oleic acid,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transcription initiation by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transcription regulatory region DNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of transferase activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of translation in response to stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of translational elongation,46.0,ANB1;EFT1;EFT2;HYP2,4.0,75.57116012140852,0.002,0.3296363636363636,1.0,1.0
positive regulation of translational fidelity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of translational initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of translational termination,46.0,ANB1;HYP2,2.0,84.0,0.001,0.259,1.0,1.0
positive regulation of transmembrane transport,101.0,RGC1;SAP185,2.0,45.49045083938936,0.027,1.0,0.999,1.0
positive regulation of transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of ubiquitin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of ubiquitin-protein transferase activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of vacuole organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
positive regulation of vesicle fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
post-chaperonin tubulin folding pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
post-translational protein targeting to endoplasmic reticulum membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"post-translational protein targeting to membrane, translocation",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
postreplication repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
potassium ion export across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
potassium ion import across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
potassium ion transmembrane transport,26.0,QDR2;SAP185;VCX1;VNX1;YVC1,5.0,102.0,0.001,0.1295,1.0,1.0
potassium ion transport,26.0,QDR2;SAP185;VCX1;VNX1;YVC1,5.0,102.0,0.001,0.1295,1.0,1.0
pre-replicative complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pre-replicative complex assembly involved in nuclear cell cycle DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
premeiotic DNA replication,22.0,LGE1;POL1,2.0,20.392591607539384,0.014,1.0,1.0,1.0
primary alcohol catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
primary alcohol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
primary cell septum biogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
programmed cell death,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proline biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proline catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proline catabolic process to glutamate,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proline metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proline transport,5.0,AVT3;NPR2,2.0,14.387640052032225,0.004,0.3816842105263158,1.0,1.0
proteasomal ubiquitin-independent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proteasome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proteasome core complex assembly,64.0,PRE2;PRE9,2.0,73.38380047335751,0.016,1.0,1.0,1.0
proteasome localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proteasome regulatory particle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proteasome storage granule assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein K11-linked ubiquitination,27.0,APC1;APC2;APC4;APC5;DOC1,5.0,36.0,0.001,0.1295,1.0,1.0
protein K63-linked ubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein N-linked glycosylation via asparagine,39.0,OST1;OST6;STT3;WBP1,4.0,100.71348036422557,0.004,0.15108333333333335,1.0,1.0
protein O-linked glycosylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein O-linked mannosylation,39.0,BFR1;DPM1;PMT1;PMT2;PMT4,5.0,126.0,0.001,0.045325000000000004,1.0,1.0
protein acetylation,49.0,ADA2;ARD1;MDM20;NAT1;NAT5,5.0,81.0,0.001,0.226625,1.0,1.0
protein acylation,49.0,ADA2;AKR1;ARD1;MDM20;NAT1;NAT5,6.0,81.0,0.001,0.226625,1.0,1.0
protein autoubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein catabolic process in the vacuole,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein complex oligomerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein deglutathionylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein deglycosylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein deglycosylation involved in glycoprotein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein deneddylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein desumoylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein deubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein exit from endoplasmic reticulum,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein folding in endoplasmic reticulum,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein histidyl modification to diphthamide,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein import into mitochondrial intermembrane space,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein import into mitochondrial matrix,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein import into peroxisome matrix,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"protein import into peroxisome matrix, docking",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"protein import into peroxisome matrix, receptor recycling",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein insertion into ER membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein insertion into membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein insertion into mitochondrial inner membrane,46.0,OXA1;TIM18;TIM54;TOM70,4.0,84.0,0.001,0.259,1.0,1.0
protein insertion into mitochondrial inner membrane from matrix,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein insertion into mitochondrial membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein insertion into mitochondrial outer membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to Golgi apparatus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to actin cytoskeleton,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to bud neck,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to cell cortex,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to cell division site,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to cell division site after cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"protein localization to cell division site involved in cytokinesis, actomyosin contractile ring assembly",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to cell periphery,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to chromatin,9.0,CDC28;SGF73;TFC3,3.0,40.36095058536254,0.032,1.0,0.999,1.0
protein localization to chromosome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"protein localization to chromosome, centromeric region",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"protein localization to chromosome, telomeric region",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to condensed chromosome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to cytoskeleton,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to eisosome filament,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to endoplasmic reticulum exit site,39.0,SEC16;YET1;YET3,3.0,126.0,0.001,0.045325000000000004,1.0,1.0
protein localization to endosome,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to membrane raft,26.0,VAC8,1.0,66.59264870462039,0.011,0.99715,1.0,1.0
protein localization to microtubule,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to microtubule cytoskeleton,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to microtubule organizing center,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to mitotic spindle pole body,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to nuclear envelope,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to nuclear inner membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to nuclear periphery,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to nucleolar rDNA repeats,6.0,RPD3;TOF2,2.0,27.75166619808371,0.003,0.18755172413793103,1.0,1.0
protein localization to phagophore assembly site,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein localization to vacuolar membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein mannosylation,39.0,BFR1;DPM1;MNN5;PMT1;PMT2;PMT4,6.0,126.0,0.001,0.045325000000000004,1.0,1.0
protein maturation by [2Fe-2S] cluster transfer,106.0,GRX5;SSQ1,2.0,44.75458761780045,0.022,0.8057777777777778,1.0,1.0
protein maturation by [4Fe-4S] cluster transfer,106.0,GRX5,1.0,49.24553600549661,0.015,0.6632926829268293,1.0,1.0
protein maturation by copper ion transfer,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein maturation by iron-sulfur cluster transfer,106.0,GRX5;SSQ1,2.0,44.75458761780045,0.022,0.8057777777777778,1.0,1.0
protein methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein modification by small protein removal,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein monoubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein neddylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein palmitoylation,37.0,AKR1,1.0,61.17681319779948,0.027,1.0,1.0,1.0
protein polymerization,28.0,ABP1;AIM21;ARC15;ARC18;ARC19;ARC35;ASK1;BNI1;CAP1;CAP2;DAD1;DAD2;DAD3;DAD4;DAM1;DUO1;HSK3;LAS17;NAP1;PFY1;SLA1;SPC110;SPC19;SPC34;SPC98;TDA2;TWF1,27.0,42.0,0.001,0.09542105263157895,1.0,1.0
protein polyubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein processing involved in protein targeting to mitochondrion,66.0,COR1,1.0,72.30100660854875,0.014,0.9568611111111112,1.0,1.0
protein quality control for misfolded or incompletely synthesized proteins,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein refolding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein retention in Golgi apparatus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein stabilization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein sumoylation,35.0,KRE29;NSE3;SMC5;SMC6,4.0,33.0,0.001,0.259,1.0,1.0
protein targeting to ER,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein targeting to vacuole involved in autophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein unfolding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein urmylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein-DNA complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein-RNA complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein-RNA complex remodeling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein-containing complex remodeling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein-lipid complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
protein-lipid complex organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proton export across plasma membrane,73.0,PMA1;PMA2,2.0,17.958800173440753,0.016,1.0,1.0,1.0
proton motive force-driven ATP synthesis,67.0,ATP1;ATP14;ATP15;ATP16;ATP17;ATP18;ATP19;ATP2;ATP20;ATP3;ATP4;ATP5;ATP6;ATP7;TIM11;VMA1,16.0,145.5480363225614,0.004,1.0,0.996,1.0
proton motive force-driven mitochondrial ATP synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
proton-transporting two-sector ATPase complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pseudouridine synthesis,23.0,CBF5;GAR1;NHP2;NOP10;PUS4;TSR3,6.0,10.468364969380163,0.018,1.0,1.0,1.0
pteridine-containing compound biosynthetic process,88.0,FOL2;MCO14;MIS1;MTD1,4.0,21.120936286320184,0.031,1.0,0.999,1.0
pteridine-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleobase biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleobase metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleoside bisphosphate biosynthetic process,106.0,CAB3;LAT1;LPD1;PDA1;PDB1;PDX1;SIS2,7.0,81.0,0.001,0.06714814814814815,1.0,1.0
purine nucleoside bisphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleoside catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleoside metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine nucleotide catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,103.25717521906697,0.001,0.06714814814814815,1.0,1.0
purine nucleotide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside diphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside diphosphate catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,103.25717521906697,0.001,0.06714814814814815,1.0,1.0
purine ribonucleoside diphosphate metabolic process,104.0,ADK1;ADK2;CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,19.0,124.14232024281705,0.001,0.06714814814814815,1.0,1.0
purine ribonucleoside metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside monophosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside monophosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine ribonucleoside triphosphate biosynthetic process,67.0,ATP1;ATP14;ATP15;ATP16;ATP17;ATP18;ATP19;ATP2;ATP20;ATP3;ATP4;ATP5;ATP6;ATP7;IMD3;IMD4;TIM11;VMA1;YNK1,19.0,144.41586320551303,0.005,1.0,0.995,1.0
purine ribonucleotide catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,103.25717521906697,0.001,0.06714814814814815,1.0,1.0
purine ribonucleotide transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
purine-containing compound catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;SAH1;TDH1;TDH2;TDH3;TPI1,18.0,99.58279933497889,0.001,0.06714814814814815,1.0,1.0
purine-containing compound transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyridine nucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyridine nucleotide catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,103.25717521906697,0.001,0.06714814814814815,1.0,1.0
pyridine-containing compound biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyridine-containing compound catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,103.25717521906697,0.001,0.06714814814814815,1.0,1.0
pyridoxal 5'-phosphate salvage,101.0,BUD17;PDX3,2.0,43.75051087880611,0.031,1.0,1.0,1.0
pyridoxal phosphate biosynthetic process,101.0,BUD17;PDX3,2.0,43.75051087880611,0.031,1.0,1.0,1.0
pyridoxine biosynthetic process,101.0,PDX3,1.0,49.916145572367995,0.019,1.0,1.0,1.0
pyridoxine metabolic process,101.0,PDX3,1.0,49.916145572367995,0.019,1.0,1.0,1.0
pyrimidine deoxyribonucleoside monophosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine deoxyribonucleoside triphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine deoxyribonucleoside triphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine deoxyribonucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleobase biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleobase metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleoside diphosphate biosynthetic process,101.0,URA6,1.0,48.65564045271634,0.021,1.0,1.0,1.0
pyrimidine nucleoside diphosphate metabolic process,101.0,URA6,1.0,48.65564045271634,0.021,1.0,1.0,1.0
pyrimidine nucleoside monophosphate biosynthetic process,101.0,CDC21;URA4;URK1,3.0,39.33987238190058,0.044,1.0,0.998,1.0
pyrimidine nucleoside triphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleoside triphosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine nucleotide metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine ribonucleoside diphosphate metabolic process,101.0,URA6,1.0,48.65564045271634,0.021,1.0,1.0,1.0
pyrimidine ribonucleoside monophosphate biosynthetic process,101.0,URA4;URK1,2.0,44.59045806093028,0.029,1.0,1.0,1.0
pyrimidine ribonucleoside triphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine ribonucleotide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine ribonucleotide metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine ribonucleotide salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine-containing compound biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine-containing compound metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyrimidine-containing compound salvage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
pyruvate metabolic process,104.0,ALD4;CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;LAT1;LPD1;PDA1;PDB1;PDC1;PDX1;PFK1;PFK2;PGI1;PGK1;PYC1;PYC2;TDH1;TDH2;TDH3;TPI1,24.0,139.85387196432177,0.001,0.06714814814814815,1.0,1.0
quinolinate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
quinolinate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rDNA chromatin condensation,6.0,HMO1;RPD3;SIN3;SMC4;TOF2;YCG1,6.0,33.0,0.001,0.06475,1.0,1.0
rRNA 2'-O-methylation,122.0,SPB1,1.0,45.26535954463594,0.013,1.0,1.0,1.0
rRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA 5'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA acetylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA base methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA pseudouridine synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
rRNA transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
re-entry into mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
re-entry into mitotic cell cycle after pheromone arrest,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
reactive nitrogen species metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
reactive oxygen species metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
receptor metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
receptor-mediated endocytosis,28.0,AKL1;ARC35;CHC1;CMD1;GLC7;HRR25;MYO5;ROD1,8.0,37.78558006070426,0.002,0.15765217391304348,1.0,1.0
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,21.0,CDC73;KIN28;RPB4;RTF1,4.0,11.123231785930573,0.014,1.0,1.0,1.0
reductive iron assimilation,75.0,AIM14,1.0,30.168627439800403,0.007,1.0,1.0,1.0
regulation of ARF protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ATP-dependent activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of Arp2/3 complex-mediated actin nucleation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of COPII vesicle coating,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA binding,77.0,CDC28;GRX3;SBA1;SPT6;SUA7,5.0,9.510159912175093,0.026,1.0,1.0,1.0
regulation of DNA biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA damage checkpoint,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA double-strand break processing,35.0,DPB4;RTT107,2.0,21.544680463259525,0.011,1.0,1.0,1.0
regulation of DNA recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA replication origin binding,77.0,CDC28;SPT6,2.0,12.27454494336405,0.009,1.0,1.0,1.0
regulation of DNA stability,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA-templated DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA-templated DNA replication initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of DNA-templated transcription initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ER to Golgi vesicle-mediated transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of G1 to G0 transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of G1/S transition of mitotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of G2/M transition of mitotic cell cycle,34.0,CDC28;CDC55;ORC1;POL2;ZDS1,5.0,12.300816016808353,0.029,1.0,1.0,1.0
regulation of Golgi organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of IRE1-mediated unfolded protein response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of MAPK cascade,33.0,AHK1;HOS2;PBS2;SIF2;SNT1,5.0,57.0,0.001,0.10072222222222223,1.0,1.0
regulation of RNA export from nucleus,112.0,ISW1,1.0,45.00666479233485,0.009,1.0,1.0,1.0
regulation of RNA polymerase II transcription preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of RNA splicing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of Ras protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of Rho protein signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of SNARE complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of TOR signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of TORC1 signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of actin filament bundle assembly,28.0,EFB1;HOF1;LAS17;PFY1,4.0,21.73978756120893,0.028,1.0,1.0,1.0
regulation of actin filament depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of actin filament organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of actin nucleation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of actin polymerization or depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of actomyosin contractile ring contraction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of actomyosin structure organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of alcohol biosynthetic process,22.0,MOT3,1.0,22.503332396167426,0.009,1.0,1.0,1.0
regulation of anaphase-promoting complex-dependent catabolic process,27.0,MND2,1.0,24.5490898867281,0.009,0.627576923076923,1.0,1.0
regulation of anatomical structure morphogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of antisense RNA transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of apoptotic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of attachment of spindle microtubules to kinetochore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of autophagosome assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of autophagy of mitochondrion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of binding,77.0,CDC28;GRX3;MPT5;SBA1;SNU13;SPT6;SUA7;YHC1,8.0,8.387640052032225,0.04,1.0,0.999,1.0
regulation of carbohydrate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of carbohydrate catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of carbohydrate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of catalytic activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell adhesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell cycle G2/M phase transition,34.0,CDC28;CDC55;ORC1;POL2;ZDS1,5.0,12.300816016808353,0.029,1.0,1.0,1.0
regulation of cell cycle checkpoint,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell morphogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell shape,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell size,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell wall organization or biogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cell-cell adhesion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cellular amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cellular ketone metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cellular respiration,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cellular response to amino acid starvation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cellular response to heat,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of centromere complex assembly,49.0,RIO1,1.0,58.18235291961506,0.007,1.0,1.0,1.0
regulation of chromatin organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of clathrin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"regulation of cytokinesis, actomyosin contractile ring assembly",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cytokinetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cytoplasmic mRNA processing body assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cytoplasmic translation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of cytoplasmic translational initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of dephosphorylation,73.0,IST2;SCS2,2.0,20.0,0.01,1.0,1.0,1.0
regulation of division septum assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of double-strand break repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of double-strand break repair via homologous recombination,113.0,BDF1;CDC28,2.0,33.36969535779172,0.014,1.0,1.0,1.0
regulation of double-strand break repair via nonhomologous end joining,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of endoplasmic reticulum unfolded protein response,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ergosterol biosynthetic process,22.0,MOT3,1.0,22.503332396167426,0.009,1.0,1.0,1.0
regulation of establishment of protein localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of establishment of protein localization to chromosome,18.0,GAL11;SIN4,2.0,38.3020835598307,0.015,1.0,1.0,1.0
regulation of exit from mitosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of exocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of fatty acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of filamentous growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of filamentous growth of a population of unicellular organisms,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of formin-nucleated actin cable assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of fungal-type cell wall organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of generation of precursor metabolites and energy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of gluconeogenesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of glucose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of glycogen biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of glycogen catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of glycogen metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of growth of unicellular organism as a thread of attached cells,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of heterochromatin organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of hydrolase activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of inorganic anion transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of intracellular pH,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of intracellular protein transport,39.0,POR1;SCS2;SPC2;STE24,4.0,126.0,0.001,0.045325000000000004,1.0,1.0
regulation of intracellular transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of invasive growth in response to glucose limitation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of lipid biosynthetic process,22.0,GTS1;MOT3;NPR1;NTE1;SEI1;YPK1,6.0,16.296346661343236,0.033,1.0,0.999,1.0
regulation of lipid localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of lipid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mRNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"regulation of mRNA splicing, via spliceosome",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of macroautophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mating type switching,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"regulation of mating-type specific transcription, DNA-templated",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of meiotic DNA double-strand break formation,7.0,MCM21;SET1;SPP1;SWD3;YCG1,5.0,18.0,0.001,0.9065,1.0,1.0
regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of meiotic cell cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of meiotic cell cycle phase transition,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of meiotic nuclear division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of membrane lipid distribution,75.0,DNF1;DNF2;DRS2;LEM3;YPK1,5.0,42.0,0.001,0.259,1.0,1.0
regulation of metal ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of metaphase/anaphase transition of cell cycle,27.0,APC11;APC5;CDC16;CDC23;CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;SDS24;SWM1;TPD3,14.0,36.0,0.001,0.1295,1.0,1.0
regulation of microtubule cytoskeleton organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of microtubule polymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of microtubule polymerization or depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of microtubule-based process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitochondrial DNA metabolic process,95.0,MHR1;PIM1;RIM1,3.0,34.28772782823473,0.048,1.0,0.999,1.0
regulation of mitochondrial fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitochondrion organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic actomyosin contractile ring contraction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic cell cycle DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic cell cycle spindle assembly checkpoint,27.0,CDC55;MND2,2.0,21.886904891331827,0.015,0.9669333333333334,1.0,1.0
regulation of mitotic cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic cytokinetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic nuclear division,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic recombination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic sister chromatid segregation,27.0,CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;TPD3,8.0,15.82510515149295,0.048,1.0,0.999,1.0
regulation of mitotic sister chromatid separation,27.0,APC11;APC5;CDC16;CDC23;CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;TPD3,12.0,36.0,0.001,0.1295,1.0,1.0
regulation of mitotic spindle organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of mitotic spindle pole body separation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of molecular function,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of monoatomic cation transmembrane transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of monoatomic ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ncRNA transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nitrogen utilization,8.0,DAL82;URE2;VID30,3.0,11.524912523714251,0.012,1.0,1.0,1.0
regulation of nuclear cell cycle DNA replication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nuclear-transcribed mRNA poly(A) tail shortening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nucleobase-containing compound transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nucleocytoplasmic transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of nucleotide-excision repair,77.0,CDC73;CTR9;LEO1;PAF1;RTF1;SPT4;SPT5,7.0,8.662184995396276,0.036,1.0,0.998,1.0
regulation of organelle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of pH,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion,37.0,AKR1,1.0,61.17681319779948,0.027,1.0,1.0,1.0
regulation of phosphate transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phosphatidylinositol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phosphatidylinositol dephosphorylation,73.0,IST2;SCS2,2.0,20.0,0.01,1.0,1.0,1.0
regulation of phospholipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phospholipid metabolic process,73.0,GTS1;IST2;NTE1;SCS2,4.0,17.21246399047171,0.019,1.0,1.0,1.0
regulation of phospholipid translocation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of phosphorylation,25.0,AHK1;ASC1;ASF1;BCY1;CDC11;CDC12;RPP1B;VAC14,8.0,21.0,0.001,0.1295,1.0,1.0
regulation of polysaccharide biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of polysaccharide metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of post-translational protein modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of potassium ion export across plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of programmed cell death,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of proteasomal protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of proteasomal ubiquitin-dependent protein catabolic process,27.0,MND2,1.0,24.5490898867281,0.009,0.627576923076923,1.0,1.0
regulation of protein autoubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein depolymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein desumoylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein folding,37.0,ERV2,1.0,65.43344750537715,0.021,1.0,1.0,1.0
regulation of protein import into nucleus,66.0,POR1;SCS2,2.0,54.51966033820946,0.04,1.0,1.0,1.0
regulation of protein kinase C signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein kinase activity,116.0,RPP1B,1.0,42.96090730177418,0.009,1.0,1.0,1.0
regulation of protein localization to cell division site,2.0,GIN4;GLC7;NBA1;REF2,4.0,18.02099380380648,0.023,1.0,1.0,1.0
regulation of protein localization to cell division site involved in cytokinesis,2.0,GLC7;REF2,2.0,21.129006293476127,0.012,1.0,1.0,1.0
regulation of protein localization to chromatin,9.0,CDC28;SGF73,2.0,46.473652774273646,0.019,1.0,1.0,1.0
regulation of protein localization to nucleolus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein localization to nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein modification by small protein conjugation or removal,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein phosphorylation,25.0,AHK1;ASC1;ASF1;BCY1;CDC11;CDC12;RPP1B,7.0,21.0,0.001,0.1295,1.0,1.0
regulation of protein polymerization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein secretion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein stability,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein ubiquitination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of protein-containing complex disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of proteolysis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of proteolysis involved in protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of pseudohyphal growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of rDNA heterochromatin formation,6.0,CTI6;DEP1;PHO23;RPD3;RXT2;SAP30;SDS3;SIN3,8.0,33.0,0.001,0.06475,1.0,1.0
regulation of rRNA processing,77.0,CCM1;NAN1;RIO1;SPT4;SPT5,5.0,9.051829836994363,0.031,1.0,1.0,1.0
regulation of receptor-mediated endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of reciprocal meiotic recombination,6.0,RPD3;SET2;SWI6,3.0,20.06299615038751,0.015,0.7554166666666666,1.0,1.0
regulation of response to endoplasmic reticulum stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of response to extracellular stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of response to osmotic stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ribonucleoprotein complex localization,90.0,NOG2;PPH22;REA1,3.0,38.90435974744008,0.005,1.0,1.0,1.0
regulation of ribosomal protein gene transcription by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ribosomal subunit export from nucleus,90.0,NOG2;REA1,2.0,41.92758243678696,0.004,1.0,1.0,1.0
regulation of secretion by cell,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of sexual sporulation resulting in formation of a cellular spore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of silent mating-type cassette heterochromatin formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of sister chromatid cohesion,113.0,CDC28;SPT16,2.0,30.581460078048337,0.02,1.0,1.0,1.0
regulation of sister chromatid segregation,27.0,APC1;APC11;APC2;APC5;CDC16;CDC23;CDC27;CDC55;CTF19;CTF3;DSL1;GAC1;GLC7;MND2;SDS24;SWM1;TPD3,17.0,36.0,0.001,0.1295,1.0,1.0
regulation of small GTPase mediated signal transduction,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of sphingolipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of spindle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of spindle organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of sporulation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of sporulation resulting in formation of a cellular spore,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of stress-activated protein kinase signaling cascade,33.0,HOS2;SIF2;SNT1,3.0,57.0,0.001,0.10072222222222223,1.0,1.0
regulation of telomere maintenance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of telomere maintenance via telomere lengthening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription by RNA polymerase I,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription by glucose,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription elongation by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription from RNA polymerase II promoter by glucose,77.0,SPT6;TUP1;VPS36,3.0,11.123231785930573,0.014,1.0,1.0,1.0
regulation of transcription initiation by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription regulatory region DNA binding,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transcription-coupled nucleotide-excision repair,77.0,CDC73;CTR9;LEO1;PAF1;RTF1;SPT4;SPT5,7.0,8.662184995396276,0.036,1.0,0.998,1.0
regulation of transcriptional start site selection at RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of transferase activity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of translational elongation,46.0,ANB1;ASC1;DHH1;EFT1;EFT2;GCN1;GCN20;HYP2,8.0,62.21176498925797,0.006,0.777,1.0,1.0
regulation of translational fidelity,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of translational initiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of translational initiation in response to stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of translational termination,46.0,ANB1;CAM1;ECM32;EFB1;HYP2;NEW1,6.0,62.21176498925797,0.006,0.777,0.999,1.0
regulation of transmembrane transport,39.0,PHO87;PHO90;PHO91;RGC1;SAP185;SKS1;SPC2;STE24,8.0,85.92181460354836,0.009,0.30786792452830186,0.999,1.0
regulation of triglyceride metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of ubiquitin-dependent protein catabolic process,27.0,MND2,1.0,24.5490898867281,0.009,0.627576923076923,1.0,1.0
"regulation of vacuole fusion, non-autophagic",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of vacuole organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of vesicle fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulation of vesicle-mediated transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulatory ncRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
regulatory ncRNA-mediated gene silencing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
removal of nonhomologous ends,101.0,MSH3,1.0,48.06974225615605,0.022,1.0,1.0,1.0
replication fork arrest,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
replication fork processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
replication fork progression beyond termination site,113.0,TOP2,1.0,32.83035733699774,0.015,1.0,1.0,1.0
replication-born double-strand break repair via sister chromatid exchange,9.0,ADA2,1.0,50.054543036687576,0.014,1.0,1.0,1.0
rescue of stalled ribosome,91.0,ASC1;GCN1;RQC1;RQC2;SLH1,5.0,48.0,0.001,0.9065,1.0,1.0
resolution of DNA recombination intermediates,35.0,SMC5;SMC6,2.0,18.933710389518883,0.019,1.0,1.0,1.0
resolution of meiotic recombination intermediates,113.0,TOP2,1.0,32.83035733699774,0.015,1.0,1.0,1.0
respiratory electron transport chain,66.0,CIR2;COX1;COX13;COX2;COX4;COX5A;COX5B;COX6;COX8;CYT1;NDI1;QCR10;QCR2;QCR6;QCR7;QCR8;QCR9;RIP1;SDH1;SDH2,20.0,117.0,0.001,0.09542105263157895,1.0,1.0
response to DNA integrity checkpoint signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to acid chemical,22.0,KOG1;NTH1;TPS1;YNL190W,4.0,18.45558775792689,0.021,1.0,0.999,1.0
response to alcohol,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to amino acid,22.0,KOG1,1.0,23.703921559843174,0.007,1.0,1.0,1.0
response to antibiotic,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to arsenic-containing substance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to cadmium ion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to carbohydrate,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to cell cycle checkpoint signaling,29.0,HRP1;MLP1;NUP53,3.0,20.471726222832956,0.005,0.5665625,1.0,1.0
response to cycloheximide,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to furfural,101.0,YNL134C,1.0,59.326967226259576,0.009,1.0,1.0,1.0
response to heat,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to hydrogen peroxide,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to inorganic substance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to light stimulus,112.0,RSC2,1.0,42.258012586952255,0.012,1.0,1.0,1.0
response to metal ion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to monosaccharide,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to organic cyclic compound,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to radiation,112.0,RSC2,1.0,42.258012586952255,0.012,1.0,1.0,1.0
response to reactive oxygen species,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to salt stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to spindle checkpoint signaling,29.0,MLP1;NUP53,2.0,22.040362458673968,0.003,0.36260000000000003,1.0,1.0
response to temperature stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to unfolded protein,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
response to xenobiotic stimulus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
reticulophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"retrograde protein transport, ER to cytosol",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"retrograde transport, endosome to Golgi",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"retrograde transport, vesicle recycling within Golgi",127.0,COG1;COG3;COG4,3.0,18.0,0.001,0.9065,1.0,1.0
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
retrotransposon silencing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoprotein complex localization,90.0,NOG2;PPH22;REA1,3.0,38.90435974744008,0.005,1.0,1.0,1.0
ribonucleoside catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside diphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside diphosphate catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,103.25717521906697,0.001,0.06714814814814815,1.0,1.0
ribonucleoside diphosphate metabolic process,104.0,ADK1;ADK2;CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1;URA6,20.0,121.28271184291324,0.001,0.06714814814814815,1.0,1.0
ribonucleoside metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside monophosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside monophosphate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleoside triphosphate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribonucleotide catabolic process,104.0,CDC19;ENO1;ENO2;FBA1;GPM1;HXK1;HXK2;PDA1;PDB1;PFK1;PFK2;PGI1;PGK1;TDH1;TDH2;TDH3;TPI1,17.0,103.25717521906697,0.001,0.06714814814814815,1.0,1.0
ribophagy,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribosomal large subunit assembly,125.0,BRX1;DRS1;IPI1;IPI3;LSG1;MAK11;MAK21;MRH4;MRT4;NOP53;REA1;REX4;RIX1;RPF2;RPL10;RPL11A;RPL11B;RPL12A;RPL12B;RPL14A;RPL14B;RPL25;RPL3;RPL33A;RPL40A;RPL40B;RPL5;RPL6A;RPL6B;RPP0;RRP5;RSA3;RSA4;SPB4;SQT1;SSF1;SSF2;YVH1,38.0,312.37900095331884,0.001,0.9065,0.995,0.9995513245033113
ribosomal large subunit export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribosomal small subunit assembly,62.0,ESF2;MRD1;NSR1;PWP2;RPS0A;RPS0B;RPS11A;RPS11B;RPS12;RPS14A;RPS14B;RPS15;RPS17A;RPS17B;RPS19A;RPS19B;RPS27A;RPS27B;RPS28A;RPS28B;RPS31;RPS5;RRP5;RRP7;RSM19;RSM7,26.0,231.09151525012282,0.012,1.0,0.999,1.0
ribosomal small subunit export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribosome disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ribosome-associated ubiquitin-dependent protein catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
second-messenger-mediated signaling,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
secondary alcohol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
secondary alcohol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
secondary metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
septin cytoskeleton organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
septin ring assembly,25.0,BNI5;CBF2;CDC10;CDC12;CDC3;GIN4;SHS1;SKP1,8.0,21.0,0.001,0.1295,1.0,1.0
septin ring disassembly,25.0,CDC3,1.0,16.785580060704262,0.004,0.42658823529411766,1.0,1.0
septin ring organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
septum digestion after cytokinesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sequestering of actin monomers,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
serine family amino acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
serine family amino acid catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
serine family amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
serine import across plasma membrane,75.0,GNP1,1.0,29.356740182112787,0.008,1.0,1.0,1.0
serine transport,75.0,GNP1,1.0,29.356740182112787,0.008,1.0,1.0,1.0
siderophore transport,46.0,ENB1;FRE4;SIT1,3.0,37.98332505838676,0.044,1.0,0.999,1.0
signal peptide processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
signal transduction in response to DNA damage,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
signal transduction involved in filamentous growth,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
signal transduction involved in positive regulation of conjugation with cellular fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
single-species surface biofilm formation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sister chromatid biorientation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
small nucleolar ribonucleoprotein complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
small-subunit processome assembly,42.0,ESF2;MRD1,2.0,16.193820026016112,0.002,0.9065,1.0,1.0
snRNA 3'-end processing,54.0,LRP1;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6,11.0,69.01029995663981,0.001,0.06714814814814815,1.0,1.0
snRNA metabolic process,54.0,AIR2;BDF1;CBF5;GAR1;LRP1;MTR3;MTR4;NHP2;NOP10;PRP16;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SEN1;SKI6,19.0,61.77885755379867,0.001,0.06714814814814815,0.999,1.0
snRNA modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
snRNA processing,54.0,LRP1;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SEN1;SKI6,12.0,68.90799491174505,0.001,0.06714814814814815,1.0,1.0
snRNA pseudouridine synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sno(s)RNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sno(s)RNA metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sno(s)RNA processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sno(s)RNA transcription,2.0,CTR9;PAF1;RTF1;SSU72,4.0,17.435293172321003,0.026,1.0,1.0,1.0
snoRNA guided rRNA pseudouridine synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
snoRNA localization,42.0,ROK1,1.0,13.806179973983888,0.005,1.0,1.0,1.0
snoRNA splicing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
snoRNA transcription by RNA polymerase II,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sodium ion transmembrane transport,26.0,VNX1;YVC1,2.0,102.0,0.001,0.1295,1.0,1.0
sphingoid long-chain base transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sphingoid metabolic process,39.0,LCB1;LCB2;LCB5;TIM54,4.0,105.96090730177417,0.003,0.12086666666666666,1.0,1.0
sphingolipid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sphingosine biosynthetic process,39.0,LCB1;LCB2;LCB5;TIM54,4.0,105.96090730177417,0.003,0.12086666666666666,1.0,1.0
spindle assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spindle disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spindle elongation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spindle pole body duplication,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spindle pole body organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spliceosomal complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spliceosomal complex disassembly,13.0,DED1;NTR2;PRP43,3.0,33.913683087845314,0.044,1.0,0.998,1.0
spliceosomal conformational changes to generate catalytic conformation,10.0,BRR2;CDC40;CEF1;IST3;ISY1;PRP16;PRP19;PRP2;PRP38;PRP4;PRP45;PRP8;SLU7;SNU114;SPP381;SYF1;YJU2,17.0,171.0,0.001,0.259,1.0,1.0
spliceosomal snRNP assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spliceosomal tri-snRNP complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11),13.0,BRR2;PRP38;SNU114,3.0,75.0,0.001,0.20144444444444445,1.0,1.0
steroid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sterol biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sterol homeostasis,39.0,SPF1,1.0,72.29234875998127,0.019,0.5939137931034483,1.0,1.0
sterol import,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sterol metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sterol transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
stress granule assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
stress granule disassembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
stress-activated protein kinase signaling cascade,33.0,HOG1;HOS2;PBS2;SIF2;SNT1,5.0,57.0,0.001,0.10072222222222223,1.0,1.0
stress-induced homeostatically regulated protein degradation pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sulfate assimilation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sulfur amino acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sulfur amino acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sulfur compound catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
sulfur compound transport,85.0,MUP3;OAC1;VHT1,3.0,16.575773191777937,0.022,1.0,1.0,1.0
synaptonemal complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
synaptonemal complex organization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA 3'-end processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA 5'-end processing,3.0,GEP5;POP1;POP4;POP5;POP7;PSP2;RPM2;RRG1;RRG8,9.0,25.193820026016112,0.001,0.6043333333333334,1.0,1.0
tRNA 5'-leader removal,3.0,POP1;POP4;POP5;POP7;PSP2;RPM2,6.0,25.602059991327963,0.001,0.6043333333333334,1.0,1.0
tRNA aminoacylation for mitochondrial protein translation,46.0,GRS1;MSK1;SLM5,3.0,38.84205201184738,0.041,1.0,0.998,1.0
tRNA aminoacylation for protein translation,46.0,ARC1;CDC60;CRS1;DED81;DPS1;GLN4;GRS1;GUS1;HTS1;ILS1;KRS1;MES1;MSK1;NAM2;SES1;SLM5;THS1;TYS1;VAS1;YDR341C;YHR020W,21.0,84.0,0.001,0.259,1.0,1.0
tRNA catabolic process,54.0,AIR2;CSL4;DIS3;MTR3;MTR4;RRP4;RRP40;RRP42;RRP43;RRP45;RRP46;RRP6;SKI6;XRN1,14.0,70.70202231334012,0.001,0.06714814814814815,1.0,1.0
tRNA export from nucleus,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA gene clustering,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA import into nucleus,85.0,SIS1;SSA2;YDJ1,3.0,30.0,0.001,0.12086666666666668,1.0,1.0
tRNA methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA nucleoside ribose methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA re-export from nucleus,101.0,CRM1;MEX67;UTP9,3.0,37.729869874255456,0.05,1.0,1.0,1.0
"tRNA splicing, via endonucleolytic cleavage and ligation",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA thio-modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA threonylcarbamoyladenosine metabolic process,1.0,BUD32;KAE1;NFS1,3.0,12.386857550352083,0.017,1.0,1.0,1.0
tRNA threonylcarbamoyladenosine modification,1.0,BUD32;KAE1,2.0,13.202396533852143,0.013,1.0,1.0,1.0
tRNA transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation,88.0,ELP3;IKI3,2.0,42.0,0.001,1.0,1.0,1.0
tRNA wobble base modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA wobble position uridine thiolation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tRNA wobble uridine modification,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
telomere capping,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
telomere localization,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
telomere maintenance via recombination,1.0,BRE1;BUD32;IES3;IES4;IES5;INO80;KAE1;NHP10;RFA1;RFA2;RFA3;TOP2;YLL066C;YML133C;YRF1-2;YRF1-3;YRF1-6;YRF1-7,18.0,21.0,0.001,1.0,1.0,1.0
telomere maintenance via telomerase,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
telomere maintenance via telomere lengthening,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
telomere tethering at nuclear periphery,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
termination of RNA polymerase I transcription,112.0,CHD1;ISW1;RPA12,3.0,34.509997188502275,0.027,1.0,1.0,1.0
termination of RNA polymerase II transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"termination of RNA polymerase II transcription, exosome-dependent",2.0,PCF11;PTI1;SSU72,3.0,33.0,0.001,0.1648181818181818,1.0,1.0
"termination of RNA polymerase II transcription, poly(A)-coupled",2.0,NPL3;PCF11;PTA1;RAI1;REF2;SSU72,6.0,33.0,0.001,0.1648181818181818,1.0,1.0
termination of RNA polymerase III transcription,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tetrahydrobiopterin biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tetrahydrofolate biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tetrahydrofolate interconversion,88.0,ADE3;MET13;MIS1;SHM1;SHM2,5.0,18.991662529193373,0.044,1.0,1.0,1.0
tetrahydrofolate metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
thioester biosynthetic process,106.0,LAT1;LPD1;PDA1;PDB1;PDX1,5.0,81.0,0.001,0.06714814814814815,1.0,1.0
thioester metabolic process,106.0,FAA3;FAA4;KGD2;LAT1;LPD1;LSC1;LSC2;PDA1;PDB1;PDX1;TES1,11.0,81.0,0.001,0.06714814814814815,1.0,1.0
threonine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
threonine catabolic process,106.0,CHA1;GLY1;ILV1,3.0,35.60648659085914,0.048,1.0,0.999,1.0
threonine metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription antitermination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription by RNA polymerase III,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription elongation by RNA polymerase I,81.0,BUD27;CDC73;CTR9;HPR1;LEO1;PAF1;RPA34;RPA49;RTF1;SPT4;SPT5,11.0,123.0,0.001,0.259,1.0,1.0
transcription elongation-coupled chromatin remodeling,77.0,HIR2;SPT5,2.0,11.524912523714251,0.012,1.0,1.0,1.0
transcription initiation at RNA polymerase I promoter,81.0,RPA49;SPT15,2.0,59.6932101816387,0.035,1.0,0.999,1.0
transcription initiation at RNA polymerase III promoter,81.0,BDP1;BRF1;RPC17;RPC25;RPC31;SPT15;TFC1;TFC3,8.0,123.0,0.001,0.259,1.0,1.0
transcription open complex formation at RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription preinitiation complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription-coupled nucleotide-excision repair,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transcriptional start site selection at RNA polymerase II promoter,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
translation reinitiation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
translational frameshifting,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
translational termination,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
translesion synthesis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
transsulfuration,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
trehalose biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
trehalose catabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
trehalose metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
trehalose metabolism in response to stress,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tricarboxylic acid cycle,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tricarboxylic acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
triglyceride catabolic process,35.0,AYR1;CDC28;TGL4;YJU3,4.0,20.06299615038751,0.015,1.0,1.0,1.0
triglyceride homeostasis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
triglyceride metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tubulin complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
tyrosine transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ubiquinone biosynthetic process,106.0,CAT5;COQ3;COQ5,3.0,81.0,0.001,0.06714814814814815,1.0,1.0
ubiquitin-dependent endocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ubiquitin-dependent glycoprotein ERAD pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ubiquitin-dependent protein catabolic process via the N-end rule pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
urea cycle,101.0,CAR1,1.0,55.70374386461888,0.012,1.0,1.0,1.0
urea metabolic process,101.0,CAR1,1.0,55.70374386461888,0.012,1.0,1.0,1.0
vacuolar protein processing,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vacuolar proton-transporting V-type ATPase complex assembly,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vacuolar transmembrane transport,26.0,AVT3;VSB1;YPQ2,3.0,44.533333279030536,0.049,1.0,1.0,1.0
vacuole fusion,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"vacuole fusion, non-autophagic",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vacuole inheritance,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
valine catabolic process,106.0,EHD3;LPD1,2.0,38.04125561028453,0.039,0.9303552631578946,1.0,1.0
valine metabolic process,106.0,BAT1;BAT2;EHD3;ILV2;ILV3;ILV5;ILV6;LPD1,8.0,81.0,0.001,0.06714814814814815,1.0,1.0
very long-chain fatty acid biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
very long-chain fatty acid metabolic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle budding from membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle cargo loading,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle coating,35.0,GLO3;SEC16;SEC23;SEC28,4.0,33.0,0.001,0.259,1.0,1.0
vesicle cytoskeletal trafficking,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle docking,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle docking involved in exocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle fusion to plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle fusion with Golgi apparatus,37.0,BOS1;HRR25;SEC17;SEC18;SEC22;SLY1;YIP1,7.0,117.0,0.001,0.13946153846153847,1.0,1.0
vesicle fusion with vacuole,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"vesicle targeting, rough ER to cis-Golgi",-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
"vesicle targeting, to, from or within Golgi",35.0,GLO3;SEC16;SEC23,3.0,20.746623124624797,0.013,1.0,1.0,1.0
vesicle tethering involved in exocytosis,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vesicle transport along actin filament,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
vitamin B6 biosynthetic process,101.0,BUD17;PDX3,2.0,43.75051087880611,0.031,1.0,1.0,1.0
vitamin B6 metabolic process,101.0,BUD17;PDX3;YBL036C,3.0,87.0,0.001,0.3021666666666667,1.0,1.0
vitamin transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
wobble position ribose methylation,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
wybutosine biosynthetic process,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
xenobiotic detoxification by transmembrane export across the plasma membrane,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
xenobiotic transport,73.0,PDR15;PDR5;QDR2;SNQ2;YOR1,5.0,16.19788758288394,0.024,1.0,1.0,1.0
zinc ion transport,-1.0,,0.0,0.0,1.0,1.0,1.0,1.0
